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Abstract  
New Psychoactive Substance (NPS) use has been increasing in popularity ever since 
mephedrone was reintroduced onto the drugs market in 2007. Legislation in the form 
of the Psychoactive Substances Act (PSA; 2016) in the UK aimed to outlaw NPS’ and 
whilst they are now illegal under this Act, the nature of the market means that they 
are still constantly evolving. This project discusses the synthesis and characterisation  
of  the  mephedrone  analog  and  synthetic  cathinone  (±)-4’- 
(trifluoromethyl)methylcathinone (4-TFMMC) as well as three of its novel metabolites 
as racemic mixtures. NPS development takes place rapidly so robust reference 
standards were created pre-emptively to aid analytical bodies with the identification 
of these compounds before their anticipated debut onto the black market. Both 
mephedrone and 4-TFMMC were administered to Araneus diadematus to identify 
whether either of the compounds would have a significant effect on webbuilding, as 
the spider system is one that is well established. Though web-building is only 
governed by a few simple rules, it is a complex and intricate behavioural mechanism 
that can be easily disrupted. Mephedrone was also administered to Pardosa agrestis 
to assess whether the compound would affect hunting behaviour. Both spiders catch 
prey in drastically different ways and so the author wanted to evaluate the plasticity 
of P. agrestis and whether this system could be considered comparable to A. 
diadematus. It was found that 4-TFMMC did not significantly affect the webs that A. 
diadematus spun. Mephedrone seemed to affect the faculties of both spider systems 
in a similar way; A. diadematus spun webs with smaller free zone and capture spiral 
areas and P. agrestis exhibited diminished movement of the capture legs whilst 
capturing prey items. This study was not designed to establish the potential effects 
of the compounds on the spiders’ central nervous systems (CNS), though this is a 
route for future work to facilitate a more comprehensive understanding of how a 
spider system may be affected by synthetic cathinones.  
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Chapter 1  
Introduction  
Mephedrone and New Psychoactive Substance development  
(±)-4’-(Methyl)methcathinone, also known as mephedrone, is a synthetic cathinone 
that became a popular drug of abuse from 2007-onwards, per its reintroduction to 
the drugs market (Deluca et al., 2012). Mephedrone was arguably the first ‘legal high’ 
and was sold under non-descript pseudonyms marked with ‘plant food’ or ‘not for 
human consumption’ (Vardakou, Pistos & Spiliopoulou, 2011). Despite the PSA (UK 
Government, 2016) outlawing all present and future NPS’ the market is still evolving 
(UNODC, 2013), as such it is the duty of analytical bodies to try and anticipate these 
up-and-coming drugs of abuse. Mephedrone was fully characterised by Santali et al. 
(2011); Khreit et al. (2013) built on this as part of their research, synthesising (±)-
4’(trifluoromethyl)methcathinone (4-TFMMC) based on mephedrone’s metabolic 
pathways. They found that the structural alterations many NPS’ like mephedrone 
undergo may only be slight but can drastically alter the metabolism of the 
compounds. Data is almost always lacking for these novel compounds and so it is 
crucial that we have a comprehensive understanding and complete characterisations 
before they emerge onto the market (Hadlock et al., 2011). In this way identification 
of a substance can be expedited and thus any potential damage to a drug user and 
other exposed individuals minimised.  
Spiders as behavioural drug-testing systems  
Using spiders as a drug testing system, whilst unconventional, is by no means a novel 
idea. One group of compounds with a wealth of historical testing in a spider system 
is amphetamines (Peters & Witt, 1949; Witt & Reed, 1965; Witt, 1971; Reed, Witt & 
Scarboro, 1982), they are structurally similar and have broadly similar effects as 
cathinones in vivo (Ellefsen, Concheiro & Huestis, 2016). Peters and Witt (1949) were 
the first to publish work concerning the administration of Pervitin 
(methamphetamine) to orb-weavers to try and alter their circadian rhythms, though 
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they quickly realised that their rhythms remained unchanged and that the spiders 
producing highly disjointed webs as a side-effect instead. Witt proceeded after this 
initial study to administer other substances, including other amphetamines, to 
spiders to see how their webs were affected, comparing and contrasting the effects 
between classes and individual compounds (Witt & Reed, 1965; Witt, 1971; Reed, 
Witt & Scarboro, 1982). A paper published by NASA (Noever, Cronise & Relwani, 
1995) described administering different classes of substances to spiders, including 
amphetamines, and using computer software to evaluate the quality of webs spun. 
They concluded that the more toxic a chemical was, the more disjointed the web 
would be; though this was an arbitrary and very basic assessment of the effects of 
each compound only going off the number of cells within a web that a spider had 
completed. In more modern publications, specific measurements were taken from 
photographs of webs to give a more accurate overall assessment of a web’s 
characteristics (Hesselberg & Vollrath, 2004; Zschokke & Herberstein, 2005; Wyman, 
Rodenhouse & Bank, 2011; Zschokke, 2011) using formulae developed to precisely 
calculate these desired web metrics (Herberstein & Tso, 2000). Spider systems seem 
to be more frequently used to evaluate the impacts of pesticides on wildlife as they 
are key predators vital for pest control (Shaw, Waddicor & Langan, 2005; Hanna & 
Hanna, 2013; Benamú et al., 2013; Pasquet et al., 2016) but the versatility of the 
research means that a lot of the methodology can be applied to testing other 
substances. Though a spider system cannot be compared to humans or rodents, 
administering drugs to spiders reveals a wealth of information on the function of their 
complex behavioural patterns (Witt, 1971).  
Thesis Structure  
The two main data chapters (Chapters 2-3) of this thesis are sequential and individual 
elements, written in the style of manuscripts for scientific journals and adhering to 
subject specific formatting conventions where possible. This layout has been chosen 
with the knowledge that it may seem unconventional but due to the cross- 
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disciplinary nature of the study, the author feels it is the most suitable way to present 
the research whilst maintaining continuity. Chapter 2 is an extended discussion of the 
synthesis and characterisation of an analog of mephedrone and three of its novel 
metabolites. Therein several presumptive tests used by analytical bodies are also 
evaluated within the scope of the work. Chapter 3 focuses on the administration of 
mephedrone and 4-TFMMC to A. diadematus. The effects of the drugs on the spiders’ 
webs are discussed. Mephedrone was also administered to P. agrestis to compare 
the effects the drug had on their behaviour to A. diadematus to determine whether 
a hunting spider system (P. agrestis) is plastic enough for use in behavioural drug 
testing. Chapter 4 summarises the findings and implications of the thesis, suggesting 
avenues for further study.  
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Chapter 2  
The Complete Synthesis and Characterisation of Three Metabolites of 
the Synthetic Cathinone (±)-4’-(Trifluoromethyl)methylcathinone (4-
TFMMC)  
Abstract –  New Psychoactive Substances (NPS’) have been popular drugs of abuse 
ever since mephedrone (1b) surfaced onto the drugs market in 2007. Its widespread 
use highlighted the loopholes within the Misuse of Drugs Act (MDA, 1971) in the UK, 
prompting new legislation in the form of the Psychoactive Substances Act (PSA, 
2016). (±)-4’-(trifluoromethyl)methcathinone (4-TFMMC, 2) is an analog of 
mephedrone (1b) synthesised ahead of its expected black market debut. 4-TFMMC 
(2) has been designed specifically to restrict one of mephedrone’s key metabolic 
pathways (oxidation of the aromatic methyl moiety) and, theoretically, increase its 
half-life in vivo. Three novel metabolites were synthesised according to the 
metabolism of mephedrone (1b) and thus the assumed metabolism of 4-TFMMC (2), 
following the two unrestricted metabolic pathways remaining (N-demethylation, 
reduction). This study provides robust reference standards and comprehensive 
characterisation for 4-TFMMC (2) and the three novel synthetic metabolites. The 
possibility for the use of presumptive testing to aid in the detection of these 
compounds by analytical bodies is also discussed.  
Introduction  
Substance abuse is a pervasive societal problem, one that weighs heavily on our 
health systems and even more so on the users themselves (Dargan, Albert & Wood, 
2010; James et al., 2010). Whilst substance abuse isn’t anything new, what is are the 
novel substances crafted to target a drug-using market of, often vulnerable, 
individuals (Every-Palmer, 2010; Giese et al., 2015; Wastnedge, 2014). NPS’ are based 
on pre-existing drugs of abuse manufactured originally to evade legislation, often 
existing as ‘enhanced’ and considerably more dangerous versions of their parent 
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compounds (Ellefsen, Concheiro & Huestis, 2016). Supply and manufacture were 
officially outlawed in May 2016 as part of a blanket-ban in the UK per the introduction 
of the PSA which defines a psychoactive substance as something which “by 
stimulating or depressing the person’s central nervous system affects the person’s 
mental functioning or emotional state” (UK Government, 2016). The Act was 
introduced as a way to combat the loopholes and oversights of the MDA (UK 
Government, 1971) which outlawed compounds based on specific structures and 
classes. The MDA separated these compounds into three classes: A, B and C, as well 
as into two separate Schedules; these relate to sentencing severity and societal 
impact (Class) and their potential for therapeutic use (Schedule; The Misuse of Drugs 
Regulations 2001). A critique of the Act is that substances such as alcohol and tobacco 
were not included in the Act despite their known detrimental effects, a move that 
was described as “from a scientific perspective, arbitrary….” (Nutt et al., 2007). In 
several cases, a drug’s class was decided from a purely political perspective; cannabis 
is one such substance that has been reclassified twice (The Misuse of Drugs Act 1971 
(Modification) (No. 2) Order 2003; The Misuse of Drugs Act 1971 (Amendment) Order 
2008) as a result of shifting of opinion in British Parliament and of the serving Home 
Secretary, who retains the authority to upgrade, downgrade, or add substances based 
on recommendations from an advisory council. An important note is that NPS 
development takes place rapidly, which is something the MDA wasn’t developed to 
combat. It was because of this short-coming that more legislation, in the form of the 
PSA, was put in place so that drug legislature could become more proactive when 
targeting novel substances.  
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Table 1. Summary of nomenclature and structures of the compounds discussed 
within this chapter, excluding intermediates.  
Name  Structure  Cmpd No.  
Cathinone  
 
1  
Methcathinone  
 
1a  
Mephedrone:  
(±)-4’-(methyl)methcathinone  
 
1b  
(±)-4’- 
(trifluoromethyl)methcathinone  
 
2  
(±)-4’-(trifluoromethyl)ephedrine  
  
3  
(±)-4’-(trifluoromethyl)cathinone  
 
4  
(±)-4’-(trifluoromethyl)norephedrine  
 
5  
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Synthetic cathinones have been popular drugs of abuse ever since mephedrone (1b; 
Table 1) surfaced onto the drugs market in 2007 (Deluca et al., 2012), coining the 
term New Psychoactive Substance. (±)-4’-(Trifluoromethyl)methcathinone (4TFMMC, 
2) is structurally similar to mephedrone (1b) and methcathinone (1a), both of which 
are derived from the parent drug cathinone (1, Fig. 1) originally isolated from Catha 
edulis (Khat; Kalix & Braenden, 1985).  
 
Fig 1. The core structure of three cathinone derived analogs.  
As with long-standing drugs of abuse (e.g. cocaine, MDMA) NPS’ are frequently 
confiscated by police and other legal bodies, though unlike established drugs of abuse 
there is a stark lack of metabolic and analytical data. Cathinones were controlled 
under the MDA and have been placed under further restrictions with the 
implementation of the PSA. Despite further restrictions, NPS use is becoming more 
popular (EMCDDA, 2015) yet for the most part, we cannot be certain of the effects of 
these compounds on the human body (Capriola, 2013; UNODC, 2013). That is why, 
arguably, it is more important now than ever to anticipate and fully characterise 
compounds that we believe are up and coming NPS’ before they enter the market 
and are used by people without any knowledge of what they’re taking and how it may 
affect them. 
Mephedrone (1b) has three main routes of metabolism and these are as follows: 
Ndemethylation; reduction of the keto functionality; and CH oxidation of the 
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paramethyl functionality (Khreit et al., 2013). Khreit et al. demonstrated that the 
metabolism of 4-TFMMC (2; Scheme 1) shares some similarities with its parent 
compound, though due to the structural modification of the para-methyl moiety (CH3 
→ -CF3), its overall pharmacokinetics cannot be considered analogous to 
mephedrone (1b). This is due to the termination of the CH oxidation pathway which 
almost entirely eliminates any hydroxymethyl-groups used for glucuronidation, 
drastically slowing the metabolism of the compound. As a consequence of diminished 
metabolic pathways due to CH oxidation removal, half-life in vivo was shown to 
increase. The metabolites synthesised in this study are based on the two main routes 
of metabolism for mephedrone (1b) and the proposed metabolism of 4-TFMMC (2; 
N-demethylation and reduction). As the C-F bond would not be metabolised via 
conventional means, any aromatic hydroxymethyl-groups or other suspected 
metabolites produced from CH oxidation pathway have not been pursued in this 
study.  
 
Scheme 1. The two proposed routes of metabolism of (±)-4’- 
(trifluoromethyl)methcathinone (2) pursued. Reduction and N-demethylation yield three 
metabolites: (±)-4’-(trifluoromethyl)cathinone (4); (±)-4’-(trifluoromethyl)ephedrine (3); and 
(±)-4’-(trifluoromethyl)norephedrine (5).  
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The aim of this study is to report a comprehensive analysis (Mpt.; TLC; IR; 1H, 13C, 19F 
NMR; LC-MS; Raman) of (±)-4’-(trifluoromethyl)methcathinone and three of its 
proposed metabolites (Table 1) pre-emptively synthesised in anticipation of the 
introduction of the parent compound (4-TFMMC, 2) onto the illegal drugs market.  
Methods  
All reagents were of commercial quality (from Sigma–Aldrich, Gillingham, UK), used 
without any further purification. Where necessary, solvents (from Fisher Scientific, 
Loughborough, UK) were dried and. Melting points were determined using closed 
capillary melting tubes on Stuart SMP10 MP apparatus (Sigma-Aldrich, Gillingham, 
UK). Thin-layer chromatography (TLC) was carried out on aluminium backed SiO2 
plates (Merck, Darmstadt, Germany), the spots were visualised using ultra-violet light 
(254 nm). TLC experiments were carried out at 5 mg mL-1 and presumptive tests were 
carried out at 20 mg mL-1 in accordance with UNODC guidelines (4.6; UNODC, 2015) 
for the identification of synthetic cathinones. Reagents for these experiments were 
prepared per the same guidelines and refrigerated to prevent degradation. Infrared 
spectra were obtained in the range 4000–400 cm−1 on a ThermoScientific Nicolet 
iS10ATRFTIR instrument (ThermoScientific, Rochester, USA). High-field 1H, 13C and 19F 
NMR spectra were collected on JEOL ECS-400 Multinuclear FT-NMR (JEOL, Tokyo, 
Japan) at 400 MHz, 101 MHz and 376 MHz respectively, chemical shifts are reported 
as δ values. LC-MS data was collected on an Agilent 1260 infinity interfaced to a QTOF 
6540 UHV accurate tandem mass spectrometer; all compounds were subject to ESI at 
70 eV and values are reported as m/z ratios. Raman spectra were collected on a DXR 
Raman Microscope at 532 nm (ThermoScientific, Rochester, USA) and processed with 
OMNIC software (2008).   
See supplementary information for all data not discussed in the main text (Figure S.I- 
1.0 onwards).  
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2.1 Synthesis of (±)- 4’-(trifluoromethyl)-2-bromopropiophenone (8)  
The title compound was synthesised per the method reported by Kalendra (Kalendra 
et al., 2003). To a solution of dichloromethane (DCM; 5 mL) and propiophenone (7, 
20 mmol) was added one drop of hydrobromic acid (48% aq. solution) and one drop 
of bromine. The mixture was stirred and heated (30 minutes). When the bromine 
colour discharged, bromine (1 eq., including the original drop) was added dropwise 
whilst stirring. The reaction mixture was then concentrated in vacuo. Due to the 
bromopropiophenone’s lachrymatory properties it was not purified before being 
used in the amination step so yield and spectral data were not obtained.  
2.2 Synthesis of (±)-4’-(trifluoromethyl)methcathinone hydrochloride (2)  
The title compound was synthesised per the method reported by Santali (Santali et 
al., 2011). A suspension of (±)- 4’-(trifluoromethyl)-2-bromopropiophenone (1 eq.) 
and methylamine (2M, 1 eq.) in DCM (40 mL) was prepared. The mixture was stirred 
overnight at room temperature and then acidified (pH ≈ 1) with hydrochloric acid 
(6M, 50 mL). The aqueous layer was washed with DCM (3 × 50 mL) and then basified 
(pH ≈ 10) with potassium hydroxide (5M, ca. 100 mL) before being re-extracted with 
DCM (3 × 50 mL). The combined organic fractions were dried (MgSO4) and 
concentrated in vacuo to attain a yellow oil then suspended in diethyl ether and HCl 
in dioxane (1 eq.) before being stirred gently for 5 minutes. The resulting solid was 
recrystallized in reagent grade acetone to give an off-white powder (1.48 g, 28% 
calculated from step 2.1). Mpt. (acetone) 225˚C; Rf [SiO2, EtOAc:n-hexane (1:3)] = 
0.42; IR (ATR-FTIR) νmax (cm-1): 2900 (C-H), 2700 (N-H), 1689 (C=O), 1328 (C-F), 856 
(pAr) ; 1H NMR (400 MHz, D2O) δ 8.91 (d, 2H, J = 8.4 Hz, ArH), 7.96 (d, 2H, J = 8.4 Hz, 
ArH), 5.18 (q, 1H, J = 7.3 Hz, CHR2(CH3)), 2.86 (s, 3H, RNH(CH3)), 1.64 (d, 3H, J = 7.3 
Hz, CHR2(CH3)); 13C NMR (101 MHz, D2O) δ 199.72 (s, C=O), 138.18 (s, ArC), 137.94 (s, 
ArC), 132.29 (s, ArC), 129.15 (s, ArC), 129. 12 (s, ArC), 127.70 (s, ArC), 124.99 (s, C-F3), 
62.79 (s, CHR2(CH3)), 33.79 (s, RNH(CH3)), 17.77 (s, CHR2(CH3)). 19F NMR (376 MHz, 
D2O) δ -64.22 (CF3, s); LC-MS (ESI+, 70 eV): calculated for [M+H] C11H13NOF3: 
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232.0950, found 232.0949; RAMAN νmax (cm-1): 3089.07, 2964.92, 2939.53, 1691.14, 
1619.46, 795.35, 633.37.  
2.3 Synthesis of (±)-4’-(trifluoromethyl)ephedrine hydrochloride (3)  
The title compound was synthesised per the method reported by Pozo et al. (2015). 
(±)-4’-(Trifluoromethyl)methcathinone hydrochloride (300 mg, 1.4 mmol) was 
dissolved in anhydrous methanol (15 mL) and then chilled in an ice bath. NaBH4 (1.32 
g, 25 eq.) was added slowly and once effervescence had ceased the mixture was 
stirred for 24 hours under inert atmosphere. The reaction mixture was then 
concentrated in vacuo and then dissolved in deionised water (approx. 50 mL). This 
solution was then extracted with DCM (3 × 30 mL). The organic fractions were 
combined and dried (MgSO4) then filtered. The drying agent was also washed with 
DCM (2 × 15 mL) and the collective filtrates combined. These were concentrated in 
vacuo to attain a viscous yellow oil which was subsequently dissolved in ethyl acetate 
(approx. 2 mL) and HCl in dioxane (4M, 3 eq.) added slowly. This solution was left 
stirring for 30 minutes before the solvents were removed in vacuo and the resulting 
solid triturated with acetone (3 × 20 mL) to produce an off-white powder (261 mg, 
87%). Mpt. (acetone) 192-194˚C; Rf [SiO2, EtOAc:n-hexane (1:3)] = 0.10; IR (ATR-FTIR) 
νmax (cm-1): 3354 (O-H), 2979 (C-H), 2803 (N-H), 1325 (C-F), 1112 (C-O), 852 (p-Ar); 1H 
NMR (400 MHz, D2O) δ 7.78-7.59 (m, 4H, ArH), 5.27 (d, 1H, J = 3.1 Hz, CHR2(CH3)), 
3.61 (qd, 1H, J = 6.8, 3.3 Hz, RCH(OH)), 2.81 (s, 3H, RNH(CH3)), 1.10 (d, 3H, J = 6.8 Hz, 
CHR2(CH3)); 13C NMR (101 MHz, D2O) δ 145.89 (s, ArC), 132.83 (s, ArC), 132.51 (s, ArC), 
129.45 (s, ArC), 128.63 (s, ArC), 128.59 (s, ArC), 125.75 (s, C-F3), 73.62 (s, C-OH), 62.58  
(s, CHR2(CH3)), 33.69 (s, RNH(CH3)), 12.33 (s, CHR2(CH3)). 19F NMR (376 MHz, D2O) δ 
63.32 (CF3, s); LC-MS (ESI+, 70 eV): calculated for [M+H] C11H15NOF3: 234.1110, found 
234.1106; RAMAN νmax (cm-1): 3076.34, 1621.08 , 1324.11, 792.89, 766.80, 633.84.  
2.4 Synthesis of (±)-4’-(trifluoromethyl)cathinone hydrochloride (4)  
The title compound was synthesised per the method reported by Santali (Santali et 
al., 2011). The di-tert-butyl-iminodicarboxylate potassium starting material (7.21 g,  
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1.2 eq.) was added to a solution of (±)- 4’-(trifluoromethyl)-2-bromopropiophenone 
(7.68 g, 1 eq.) in dimethylformamide (17.5 mL) and stirred at room temperature 
overnight. The reaction mixture was then diluted with water (approx. 100 mL) and 
extracted with methyl tert-butyl ether (MTBE; 4 × 50 mL). The crude solid (±)-N, 
N(BOC)2-4’-(trifluoromethyl)cathinone was dissolved in DCM before adding HCl in 
dioxane (5 eq.) and stirring overnight. The resulting solution was filtered to get an off-
white solid which was then decolourised with acetone to yield a white solid (1.13 g, 
22% calculated from step 2.1). (acetone) 238˚C; Rf [SiO2, EtOAc:n-hexane (1:3)] = 0.47; 
IR (ATR-FTIR) νmax (cm-1): 2883 (C-H), 2700 (N-H), 1691 (C=O), 1329 (C-F), 855 (pAr); 
1H NMR (400 MHz, D2O) δ 8.18-7.95 (m, 4H, ArH), 5.26 (q, 1H, J = 7.3 Hz, CHR2(CH3)), 
1.62 (d, 3H, J = 7.3 Hz, CHR2(CH3)). 13C NMR (101 MHz, D2O) δ 200.22 (s, C=O), 138.26 
(s, ArC), 137.88 (s, ArC), 133.01 (s, ArC), 132.34 (s, ArC), 130.70 (s, ArC), 129.18 (s, 
ArC),  125.11 (s, C-F3), 55.23 (s, CHR2(CH3)), 19.27 (s, CHR2(CH3)); 19F NMR (376 MHz, 
D2O) δ -64.17 (CF3, s); LC-MS (ESI+, 70 eV): calculated for [M+H] C10H11NOF3: 
218.0793, found 218.0793; RAMAN νmax (cm-1): 3079.88, 2962.66, 1692.33, 1618.93, 
788.10, 633.11.  
2.5 Synthesis of (±)-4’-(trifluoromethyl)norephedrine hydrochloride (5)  
The title compound was synthesised per the method reported by Pozo et al. (2015) 
as in methods section 2.3 (219 mg, 73%). Mpt. (acetone) 210˚C; Rf [SiO2, 
EtOAc:nhexane (1:3)] = 0.15; IR (ATR-FTIR) νmax (cm-1): 3268 (O-H), 2852 (C-H), 1320 
(C-F), 1065 (C-O), 849 (p-Ar); 1H NMR (400 MHz, D2O) δ 7.78 (d, 2H, J = 8.1 Hz, ArH), 
7.59 (d, 2H, J = 8.0 Hz, ArH), 5.10 (d, 1H, J = 3.7 Hz, CHR2(CH3)), 3.85 – 3.63 (m, 1H, 
CH(OH)), 1.14 (d, 3H, J = 6.8 Hz, CHR2(CH3)). 13C NMR (101 MHz, D2O) δ 145.79 (s, 
ArC), 132.97  
(s, ArC), 132.65 (s, ArC), 129.71 (s, ArC), 128.68 (s, ArC), 128.64 (s, ArC), 125.74 (s, 
CF3), 75.16 (s, C-OH), 54.89 (s, CHR2(CH3)), 14.83 (s, CHR2(CH3)). 19F NMR (376 MHz, 
D2O) δ -63.32 (CF3, s); LC-MS (ESI+, 70 eV): calculated for [M+H] C10H13NOF3:  
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220.0950, found 220.0949; RAMAN νmax (cm-1): 3075.02, 2946.66, 1622.44, 803.70, 
766.48, 632.91.  
Results & Discussion  
 
Scheme 2. Synthesis of target compounds/key metabolites of 4-TFMMC (2).  Reagents and 
conditions: (a) Br2/HBr (48% in water)/DCM/rt/1 h; (b) MeNH2/DCM/rt/24 h; (c) 
MeOH/NaBH4/rt/24 h; (d) DMF/(BOC)2N-K+/rt/24 h; (e) DCM/HCl (4M in dioxane)/rt/24 h.  
Synthesis of the parent compound (2; Scheme 2) from the commercially available 
starting material (7) was carried out via an α-bromination (a) and subsequent 
amination (b), before being isolated as its corresponding hydrochloride salt. The 
three metabolites synthesised (3, 4, 5) were also converted to salts to prevent 
degradation in their freebase forms (Nigg & Seigler, 2013).  To produce products 4 
and 5, compound 8 was aminated via a di-tert-butyl-iminodicarboxylate protecting 
group (d) to yield a primary amine after deprotection (7; e). It was shown that Santali 
(Santali et al., 2011) method used could be optimised by directly deprotecting 7 
without the need for purification via column chromatography to produce 4. 
Compounds 2 and 4 were reduced (c) with 25 eq. of NaBH4 to accommodate for any 
residual water that may have been present. Acetone was used for purification (via 
recrystallization) for all products instead of diethyl ether and proved effective as 
another modification to the original method. Stereochemistry was not controlled in 
any reaction as it is not expected that enantiopure products will enter the market.  
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The first step in the synthesis (a) is an α-bromination of the commercially available 
propiophenone (7). The hydrobromic acid added to the reaction flask catalyses the 
formation of the enolate intermediate that subsequently attacks the δ+ centre of the 
bromine. Progression of the bromination can easily be observed as the bromine in 
the reaction flask decolourises. This reaction produces a brominated propiophenone 
(8) and installs a good leaving group which can be exploited in further reactions. If 
4TFMMC (2) or R.4-TFMMC (3) are the desired products, the next step of the reaction 
is an amination proceeding via an SN2 reaction using methylamine (b) to produce the 
parent compound 4-TFMMC (2). If 4-TFMC (4) or R.4-TFMC (5) are wanted, the 
bromopropiophenone (8) must first be aminated using a di-tert-butyl- 
iminodicarboxylate salt (d) to form a protected intermediate (9). Deprotection of the 
intermediate (8; Scheme 3; e) yields synthetic metabolite 4-TFMC (4). The reduction 
steps (c) to produce synthetic metabolites R.4-TFMMC (3) and R.4-TFMC (5) are the 
same in both instances, using sodium borohydride to reduce the carbonyl 
functionality, yielding an ephedrine (3) and a norephedrine (5) respectively.  
 
  
Scheme 3. Mechanism for the acid catalysed deprotection of a BOC protecting group (e). The 
tert-butyl cation can either be quenched, polymerised, or deprotonated to form isobutylene 
(gas) as in this example. The CO2 produced should also be allowed to leave the reaction flask.  
Due to the novel nature of the synthesis carried out in this study, no published work 
exists pertaining to the Nuclear Magnetic Resonance data of 4-TFMMC (2) and its 
metabolites in D2O. As such, when assigning structural positions for the parent 
compound (2), data was compared with spectra obtained in d6-DMSO (Khreit et al., 
2013) and cross-referenced against structural data of mephedrone (1b) collected in 
D2O (Alotaibi, Husbands & Blagbrough, 2015). The spectra of the synthetic 
metabolites (3, 4, 5) were assigned in a similar way, corroborating the absence and 
appearance of peaks between structures (Santali et al., 2011; Khreit et al., 2013; Pozo 
et al., 2015). A comparison of the primary and secondary amine peaks cannot be 
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made due to the deuterium exchange of the samples with the NMR solvent. D2O was 
chosen for analysis despite this because of the large library of sample spectra already 
obtained allowing for ease of comparison between pre-existing analogs. 
The 1H NMR spectrum of the 4-TFMMC hydrochloride salt (2; obtained in D2O; Fig. 2) 
showed five proton environments, accounting for the loss of the secondary amine 
peak due to deuteration. The asymmetrically para-disubstituted aromatic ring (8.91 
ppm, 2H, J = 8.4 Hz, AA’BB’; 7.96 ppm, 2H, J = 8.4 Hz, AA’BB’); a deshielded single 
hydrogen quartet (5.18 ppm, 1H, J = 7.3 Hz, CH(CH3)) pertaining to the chiral carbon 
as a result of the neighbouring methyl moiety. A deshielded methyl singlet appears 
at 2.86 ppm (NHCH3), and finally the methyl doublet attached to the chiral centre 
(1.64 ppm, 3H, J = 7.3 Hz, CH(CH3)). The 13C NMR spectrum (obtained in D2O) supports 
the supposition that the compound is sufficiently pure, with 11 peaks overall and 
allows for the identification of groups not visible in the 1H NMR such as the key peaks 
at 199.72 ppm (C=O) and 124.99 ppm (ArC(CF3)) respectively. Peaks at 62.79 ppm 
(CH(CH3) and 33.79 ppm (NH(CH3)) confirm the methyl groups observed in the 1H  
NMR spectrum. The CF3 group present at the para position gives rise to a singlet at 
64.22 ppm in the 19F NMR spectrum (obtained in D2O; Fig. 3) confirming the signal 
seen in the 13C NMR spectrum. Synthesis of 4-TFMMC (2) was confirmed via LC-MS 
with the molecular ion being found as 232.0949 m/z. 
All Raman spectra were assigned based on the analysis of cathinone regioisomers 
carried out by Christie et al. (Christie et al., 2013). The Raman spectrum of 4-TFMMC 
(2, Fig. 4) clearly shows several characteristic peaks associated with cathinones. The 
first peak corresponds to the C=O stretch at 1691.14 cm-1; the second to the C=C 
stretch at 1619.46 cm-1, the sharp intensity of the latter would generally be 
considered unusual but occurs as a result of the unconjugated 1,4-disubstitution on 
the aromatic ring. The peak observed at 795.35 cm-1 arises due to ν4 C-H out-of-plane 
bending and puckering around the aromatic ring. A relatively sharp signal is also 
present at 633.37 cm-1 that we tenuously assign as p-C-Ar stretching; this deviates 
considerably from literature value for the CH3-Ar stretch seen in mephedrone (1b; 
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517.9 cm-1). We believe the band occurs at higher energy as a result of the added 
steric bulk and electronic properties of the highly electronegative trifluoromethyl 
moiety.  
 
Fig. 2. 1H NMR spectrum (400 MHz, D2O) of (±)-4’-(trifluoromethyl)methcathinone (2). 
  
Fig. 3. Compiled and overlaid 19F NMR spectra (376 MHz, D2O) of all four compounds (L-R): 
R.4-TFMMC (3; purple), R.4-TFMC (5; red), 4-TFMC (4; blue), 4-TFMMC (2; purple).  
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Fig. 4. Raman spectrum of (±)-4’-(trifluoromethyl)methcathinone (2). Black arrows indicate 
peaks 1691.14 cm-1 (C=O), 1619.46 cm-1 (C=C), 795.35 cm-1 (ArC-H), and 633.37 cm-1 (Ar-CF3) 
respectively. 
Infrared data yielded several key peaks for 4-TFMMC (2): C-H methyl peaks at 2900 
and 2700 cm-1; a sharp ketone peak at 1689 cm-1; C-F peak at 1328 cm-1; and a 
paradisubstituted aromatic peak at 856 cm-1. Infrared and Raman analysis, whilst 
often only used to confirm a structure, become incredibly useful as diagnostic tools 
when compared against a library of reference standards. Both methods require only 
a small amount of sample when we compare them to Nuclear Magnetic Resonance 
spectroscopy, with the added advantage of having a lower instrument cost. NPS’ 
generally undergo less sample modification than their illicit counterparts ergo suffer 
from less matrix interference with these techniques.  
Demethylation of the parent compound (2) to a primary amine leads to an increase 
in polarity and would be expected to cause small but distinct chemical shift changes 
in the 1H and 13C NMR spectra. The synthetic metabolite 4-TFMC (4) differs in a 
couple of notable ways from its parent compound (2). Firstly, the 1H NMR spectra 
(obtained in D2O; Fig. 5) shows the disappearance of the methyl group attached to 
the amine functionality (Table 2), suggesting that the secondary amine of the parent 
compound is no longer present. This disappearance is reflected in the mass 
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reduction of the molecular ion (2: [M+H]: 232.0949 m/z, 4: [M+H]: 218.0793 m/z) as 
well as the 13C NMR, with the loss of the 62.79 ppm signal resulting in 10 instead of 
11 carbon environments. Another noticeable difference between the parent 
compound and the demethylated metabolite (4) is the shifting of the quartet 
representing the chiral carbon to higher field, as well the doublet representing the 
methyl moiety on the chiral carbon moving to lower field, indicating increased 
polarity within the system due to the presence of the primary amine.  
  
 Fig. 5. 1H NMR spectrum (400 MHz, D2O) of (±)-4’-(trifluoromethyl)cathinone (4).  
The Raman spectrum for 4 (Fig. 6) displays little variation when compared to that of 
the parent compound (2). The only peak that moves significantly is the one assigned 
to the ν4 C-H out-of-plane bending and puckering (788.10 cm-1). We suggest that the 
shift may arise as a result of the afore mentioned increase in polarity of 4 as a result 
of demethylation. The Infrared spectrum for 4-TFMC is also very similar to 2, with 
no loss or addition of peaks and all key peaks showing little-to-no variation.  
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Fig. 6. Raman spectrum of (±)-4’-(trifluoromethyl)cathinone (4). Black arrows indicate peaks 
1692.33 cm-1 (C=O), 1618.93 cm-1 (C=C), 788.10 cm-1 (ArC-H), and 633.11 cm-1 (Ar-pC) 
respectively.  
Table 2. 1H, 13C, 19F NMR data (excluding the aromatic ring) comparing key peaks in ppm for 
all four compounds. Black boxes indicate no data is available for the specific peak.  
NMR  Peak  4-TFMMC (2)  3  4-TFMC (4)  5  
1H NMR  
    
CHR2(CH3)  
CH(OH)  
RNH(CH3)  
CHR2(CH3)  
5.18  5.27  5.26  5.10  
  3.61    3.85-3.63  
2.86  2.81      
1.64  1.10  1.62  1.14  
13 C NMR  
  
     
C=O  
C-F3  
C-OH  
CHR2(CH3)  
RNH(CH3)  
CHR2(CH3)  
199.72    200.22    
124.99  125.75  125.11  125.74  
  73.62    75.16  
62.79  62.58  55.23  54.89  
33.79  33.69      
17.77  12.33  19.27  14.83  
19F NMR  C-F3  -64.22  -63.32  -64.17  -63.32  
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The 1H-NMR for (±)-4’-(trifluoromethyl)ephedrine (3; obtained in D2O; Fig. 7) displays 
six proton environments and bears resemblance to the parent compound (2): the 
para-disubstituted aromatic ring (7.78 ppm, 2H, J = 8.3 Hz, AA’BB’; 7.59 ppm, 2H, J =  
8.1 Hz, AA’BB’); the proton at 5.27 ppm is now a doublet, suggesting a loss in coupling 
(5.27 ppm, 1H, J = 3.1) compared to its unreduced counterpart (2); a new signal 
appears at 3.61 ppm (3.61 ppm, J = 6.8, 3.3 Hz) corresponding to the CH of the alcohol 
group that presents as a multiplet due to the complex coupling that results from the 
free rotation around this bond. As with 2, there is a deshielded methyl singlet present 
(2.81 ppm,3H, NHCH3), and finally the methyl doublet attached to the chiral centre 
(1.10 ppm, 3H, J = 6.8 Hz, CH(CH3)).  
  
Fig. 7. 1H NMR spectrum (400 MHz, D2O) of (±)-4’-(trifluoromethyl)ephedrine (3).  
The 1H NMR for (±)-4’-(trifluoromethyl)norephedrine (5; obtained in D2O; Fig. 8) 
displays five distinct proton environments. The para-disubstituted aromatic ring (7.78 
ppm, 2H, J = 8.1 Hz, AA’BB’; 7.59 ppm, 2H, J = 8.0 Hz, AA’BB’); the proton at 5.10 ppm 
is a doublet (J = 3.7 Hz) echoing the loss in coupling we see in (±)-
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4’(trifluoromethyl)ephedrine (3). Another similarity between synthetic metabolites 3 
and 5 is the presence of the additional CH peak when compared to the cathinones 2 
and 4 due to the reduction of the keto- moiety, because of this we witness the 
additional shift of this CH peak in the reduced metabolite 5 to lower field. No Nmethyl 
peak is observed for 5 (Table 2) in comparison to compound 3 due to the presence of 
a primary amine, this loss is confirmed by the reduction in the mass of the molecular 
ion (3 [M+H]: 234.1106 m/z, 5 [M+H]: 220.0949). The methyl group attached to the 
chiral centre appears as a doublet at 1.14 ppm (J = 6.8 Hz).  
  
Fig. 8. 1H NMR spectrum (400 MHz, D2O) of (±)-4’-(trifluoromethyl)norephedrine (5).  
Reduction of the keto-functionality reveals only a few changes with regards to the 13C 
NMR spectra of (±)-4’-(trifluoromethyl)ephedrine (3; obtained in D2O) and R.4-TFMC 
(5; obtained in D2O): 11 environments are observed for 3, as with 2, and 10 
environments are seen for 5, as with 4. The additional peak seen in the 1H NMR of 
(±)-4’-(trifluoromethyl)ephedrine (3) is confirmed by the mass of the molecular ion, 
which also indicates that the parent drug (2) was successfully reduced (2: [M+H]: 
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232.0949 m/z → 3: [M+H]: 234.1106 m/z). Notably there is the disappearance of the 
carbonyl peak (199.72 ppm) and the addition of an alcohol peak (73.62 ppm), typically 
seen in any reduction of a C=O bond. The same change is observed in the 13C NMR 
spectrum of R.4-TFMC with the alcohol peak at 75.16 ppm. The carbon of the para-
methyl functionality produces a peak at approximately 125 ppm for both 3 and 5. One 
peak that differs considerably between the two reduced compounds is the chiral 
carbon at 62.58 ppm (3) and 54.89 ppm (5), the difference is because of the increased 
polarity of 5 due to demethylation and is a key peak when looking to differentiate the 
methylated and demethylated metabolites. The peak at 33.69 ppm for (±)-4’-
(trifluoromethyl)ephedrine (3) indicates the N-methyl, confirming what is seen in the 
1H NMR spectrum; due to the lack of an N-methyl group in (±)-
4’(trifluoromethyl)norephedrine (5) this peak does not appear (Table 2). The peak at  
12.33 ppm represents the methyl moiety on the chiral carbon (CH(CH3).  
The 19F NMR spectrum (obtained in D2O; Fig. 3) shows a singlet peak at -63.32 ppm 
for both reduced metabolites (3, 5), as such it is extremely unlikely that either 
reduced synthetic metabolite could be distinguished from the other using this 
technique.  
Raman analysis confirms the loss of the keto- functionality by the disappearance of  
the  corresponding  C=O  peak  at  1691.14  cm-1  for  both  (±)-4’- 
(trifluoromethyl)ephedrine (3; Fig. 9) and (±)-4’-(trifluoromethyl)norephedrine (5; 
Fig. 10); the OH stretch does not seem to be Raman active for either reduced 
synthetic metabolite (3, 5). The C=C stretch is observed at approximately 1620 cm-1 
across all compounds, its value changing only minutely. The ν4 C-H out-of-plane 
bending and ring puckering remains at 792.62 cm-1 (3) and 803.70 cm-1 (5), with an 
additional peak at approximately 766 cm-1 for both reduced synthetic metabolites 
that we propose arises as a result of ring interactions with the trifluoromethyl moiety, 
as the system now has free rotation due to the ketone reduction.  
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The Infrared spectra of 3 and 5, similarly to the NMR data, show the loss of the ketone 
peak (1689 cm-1) with the appearance of alcohol peaks at 3354 cm-1 (3) and 3268 cm1 
(5) as well as C-O peaks at 1112 cm-1 (3) and 1065 cm-1 (5) per the reduction of the 
cathinones. Other signals observed are methyl peaks (3: 2979 cm-1, 5: 2803 cm-1); 
carbofluoro peaks (3: 1325 cm-1, 5: 1320 cm-1); and para-disubstituted aromatic peaks 
(3: 852 cm-1, 5: 849 cm-1), all with very similar values to the parent compound (2). 
 
Fig. 9. Raman spectrum of (±)-4’-(trifluoromethyl)ephedrine (3). Black arrows indicate peaks 
1621.08 cm-1 (C=C), 1324.11 cm-1 (ArC-H), 792.89 cm-1 (ArC-H), 766.80 cm-1 (Ar-CF3), and 
633.84 cm-1 (Ar-pC) respectively.  
 
Fig. 10. Raman spectrum of (±)-4’-(trifluoromethyl)norephedrine (5). Black arrows indicate 
peaks 1622.44 cm-1 (C=C), 803.70 cm-1 (ArC-H), 766.48 cm-1 (Ar-CF3), and 632.91 cm-1 (Ar-pC) 
respectively.  
 
 
27  
  
Using 1H NMR and 19F NMR, characteristic peaks can be used to distinguish between 
the cathinones and the ephedrines such as the CH of the alcohol groups that would 
only be present in the reduced metabolites. With these two techniques, it is not 
possible to discriminate between these four compounds directly. However, all four 
compounds display unique signals for the methyl moiety (C3) connected to the chiral 
carbon (C2) in their respective 13C NMR spectra, ergo we suggest here that these 
peaks could be used to identify these compounds when in a mixture (Fig. 11). 
Unfortunately in practice, employing NMR to separate and identify NPS’ isn’t realistic 
when dealing with clinical samples as it requires significantly higher concentrations 
due to the low detection limits of the technique (mmol vs. nmol). In these cases LCMS, 
utilising a HILIC based column, would be better suited as it provides the most ideal 
limits of detection.  
  
Fig. 11. A magnified section of the overlaid 13C NMR spectra of 4-TFMMC (2, blue), R.4TFMMC 
(3, purple), 4-TFMC (4, red), and R.4-TFMC (5, green) showing the C3 peak for identification 
of the four compounds.   
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Presumptive Testing  
Presumptive tests offer a cheap way for individuals without specialist equipment or 
expertise to rapidly test for specific compounds. The tests are incredibly useful as 
diagnostic tools, often employed by police to aid in the identification of unknown 
substances, giving an indication of whether a drug may be present (UNODC, 2005).  
The presumptive tests used in this study have been selected for the testing of the 
fluorinated analogs because they have been shown to detect cathinones and 
derivatives in previous work (UNODC, 1994; UNODC, 2005; UNODC, 2015). It should 
be noted that a positive reaction will vary depending on the compound being tested; 
UNODC Guidelines should be consulted for officially observed colour changes.  
Simon’s Test: This test is generally used to detect secondary amines (UNODC, 2005). 
A positive reaction produces an array of colour changes depending on the substance 
being tested. The secondary amine of the analyte reacts under alkaline conditions 
with the acetaldehyde present before complexing with the sodium nitroprusside. 
Despite being designed to detect secondary amines, primary amines can also react, 
as shown in the case of 4-TFMC (4).  
Robadope Test: The Robadope test is a variation of the Simon’s test that uses acetone 
as a reaction partner instead of acetaldehyde (UNODC, 2005). The alteration is 
designed to detect primary amine functionality specifically. However, it should be 
noted that not all primary amines will react with the Robadope test, as in the case of 
cathinone (1), that produce a positive reaction with the Simon’s test.  
Zimmerman’s Test: A test for alkaloids that can be used to detect cathinones. There 
will often be an initial colour change followed by a second colour change that 
becomes apparent after five minutes. Both colour changes are the differentiating 
criteria when identifying the compounds being tested (UNODC, 2015). The test 
operates via the formation of a Meisenheimer complex (UNODC, 1989) that is then 
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oxidised by the base present to produce a strongly coloured enolate (Wubbels, Winitz 
& Whitaker, 1990).  
Liebermann’s Test: A test used for the detection of cathinones, including 
methcathinone (1a) and mephedrone (1b; Toole et al., 2012). A positive result for 
cathinones will be bright yellow, though the mechanism for this colour change 
remains unclear.  
Chen-Kao Test: Used to distinguish ephedrines and methcathinones from 
amphetamines (UNODC, 2005). A result is considered to be positive with a colour 
change from the pale blue colour of the copper sulphate to violet or brown/orange. 
This is due to the formation of a complex between the ephedrine and the copper ions 
present in solution. The ephedrine or methcathinone act as bidentate ligands in the 
alkaline solution that form an intensely coloured four co-ordinate complex, variations 
in binding energy and structure lead to the difference in observed colour.  
A limitation of presumptive tests is the requirement of a relatively large sample 
amount when compared to other analytical methods, so for trace analysis their use 
isn’t possible. They may also generate false positives or false negatives depending on 
how the tests were prepared as well as the time from preparation to usage. It is fair 
to say that the tests are generally more helpful in identification when trying to 
determine the class of a compound rather than pinpoint a specific structure due to 
the broad spectrum of (often) subjective colour changes. Nevertheless, presumptive 
tests should not be discounted from an analyst’s toolset if only for the minimal 
equipment and training requirements where more sophisticated instruments may 
not be available.  
Colour changes should be recorded directly after samples have been added to test 
wells in addition to any further changes five minutes later. The fluorinated analogs 
generally reacted as expected, although there were some instances where 
unexpected positives or negatives were observed. One notable negative reaction is 
that of 4-TFMC (4) with the Liebermann test, though one possible explanation could 
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be that the amount of the metabolite was too low to be detected using standardised 
concentrations.   
It is tenuously suggested that from these results (Table 3) the Chen-Kao test would 
be the most reliable for distinguishing between these compounds as both the 
cathinones and ephedrines give starkly different positive reactions. Both the 
Robadope and Simon’s tests yielded more unexpected results than anticipated 
positives or negatives. As such they cannot be recommended for testing these 
compounds based on the results obtained, as the colour changes are very slight and 
could be seen as misleading.  
Table 3. Summary of overall colour changes from 0 to 5 minutes after samples were added 
to wells. (-) indicates a negative result i.e. no colour change. (+) indicates a positive result, 
unexpected positive results are not marked specifically, reported only as a ‘colour change 
(+)’.  
Presumptive 
tests:  
Robadope  Simon’s  Zimmerman’s  Liebermann’s  Chen-Kao  
4-TFMMC (2)  
  
Olive/ 
brown  
(+)  
(-)  
Peach  
(+)  
Yellow→  
Grey  
(+)  
Green→ 
orange/  
brown  
(+)  
3  (-)  (-)  (-)  
Yellow→  
Grey  
(+)  
Violet→  
Grey  
(+)  
4-TFMC (4)  
  
Light pink/ 
peach  
(+)  
Light  
orange/ 
peach  
(+)  
Light 
pink/peach  
(+)  
(-)  
Violet→  
Orange  
(+)  
5  
Light pink/ 
peach  
(+)  
(-)  (-)  
Yellow→  
Grey  
(+)  
Violet  
(+)  
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Conclusions  
The successful synthesis of (±)-4’-(trifluoromethyl)methcathinone and three of its 
novel metabolites: (±)-4’-(trifluoromethyl)ephedrine (3), (±)-4’- 
(trifluoromethyl)cathinone (4), (±)-4’-(trifluoromethyl)norephedrine (5) is reported. 
We report the first 1H NMR, 13C NMR, 19F NMR, Raman, LC-MS, and FTIR data for 
compounds 3, 4, and 5. It has also been demonstrated that all four compounds can 
be tenuously identified using presumptive testing. Future work should include the 
development of a chromatographic method using hydrophobic interaction 
chromatography (HILIC) and perhaps more comprehensive characterisation using 
presumptive tests with samples attained from matrices such as urine or blood. It is 
hoped that this work will be used to evaluate the potential metabolic pathways in 
humans as well as expedite identification in the case of police drug seizures and 
hospital admittance.   
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Chapter 3  
Administration of Synthetic Cathinones Significantly Affects Some Prey-
Capturing Behaviours of Araneus diadematus and Pardosa agrestis.  
Abstract  
The NPS market is constantly evolving and with these developments comes the 
introduction of novel compounds for which no metabolic data is available. 
Invertebrates have been shown to be good systems for chemical testing; arachnids 
are particularly useful when assessing the effects of compounds that affect the CNS. 
Administering substances to orb-weaving arachnid models such as Araneus 
diadematus can affect the webs they spin the following day due to the complexity 
and sensitivity of their behavioural patterns. We used A. diadematus to study the 
effects of the synthetic cathinone mephedrone (1b) and one of its analogs (±)-
4’(trifluoromethyl)methylcathinone (4-TFMMC, 2). We also administered 
mephedrone (1b) to Pardosa agrestis to judge whether hunting spiders could be used 
for behavioural drug testing similarly to A. diadematus. 4-TFMMC (2) was shown to 
have no significant effects on a web’s appearance and mephedrone (1b) significantly 
affected some aspects of the spiders’ webs. Mephedrone (1b) webs showed a general 
trend towards smaller capture spiral and free zone areas and though the latter 
seemed to recover with time, capture spiral areas did not return to pre-drug levels. 
Several spiders dosed with mephedrone (1b) spun multiple hubs per web and some 
webs produced were considered completely illegible because of their highly 
disjointed nature. Mephedrone (1b) significantly reduced the maximum amplitude of 
the capture legs in P. agrestis during prey capture, though back legs were not 
significantly affected. The velocity of the capture legs was also not significantly 
affected by mephedrone (1b). A. diadematus appears to be a suitable system for the 
testing of synthetic cathinones and P. agrestis shows promise for future arachnid 
based drug trials.  
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Introduction  
Invertebrate models are an appealing prospect for chemically induced behavioural 
analysis as they offer low-risk testing and high sample volume whilst still being able 
to collect data in a controlled and concise manner (Cattaneo et al., 2009). Arachnids 
in particular, exhibit precise and complex behaviours and movements when actively 
hunting and web building that can be measured and quantified. This identifies them 
as ideal candidates for the exploration of the biological effects of compounds such as 
mephedrone (1b) and other NPS’, where human metabolic data may not be available 
(Hadlock et al., 2011; Capriola, 2013).  
Cathinone is a monoamine alkaloid derived from the African shrub Catha edulis (Khat; 
Kalix & Braenden, 1985) and has a similar structure to amphetamine and 
methcathinone. The NPS mephedrone (1b) is an analog of methcathinone and as such 
is part of the cathinone class of compounds. NPS’ are compounds based on 
preexisting drugs of abuse that have been structurally modified, the aim being to 
mimic pharmacological effects whilst also avoiding legislation (Schifano et al., 2011). 
In the UK, the PSA (UK Government 2016) has outlawed all NPS’ not already legislated 
against in the MDA (UK Government, 1971). This blanket ban restricts any substance 
not otherwise classified under the MDA that has a psychological effect on the user, 
aiming to eradicate the widespread usage of these ex- ‘legal highs’ by combatting 
distribution and sales of substances under nondescript and ambiguous pseudonyms 
online and in head shops (Vardakou, Pistos & Spiliopoulou, 2011). In many cases a 
newly developed NPS will exist as an ‘enhanced’ analog of a pre-existing drug of abuse 
(Winstock et al., 2010; Ellefsen, Concheiro & Huestis, 2016); this can often be 
hazardous to an unsuspecting user who may think they are taking something less 
potent or completely different (Camilleri, et al., 2010).  
One of many problems faced when trying to control the NPS market is its constant 
evolution (UNODC, 2013). (±)-4’-(trifluoromethyl)methylcathinone (4-TFMMC, 2) is 
an NPS that is an analog of mephedrone (1b) that, to our knowledge, has not yet 
emerged onto the NPS market. It has been synthesised specifically to act as a more 
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potent version of its parent compound mephedrone (1b) and this has been achieved 
by the restriction of one of mephedrone’s three primary metabolic pathways, 
preventing CH oxidation from taking place at the para-methyl moiety (Khreit et al., 
2013). It is expected that because of this modification half-life in vivo will be greatly 
increased because of the almost complete prevention of glucuronidation due to a lack 
of hydroxymethyl-moieties. It was expected that this alteration would prolong the 
effects of the compound, possibly resulting in greater toxicity within the system.  
Araneus diadematus (Cross Orb-weaver) and Pardosa agrestis (wolf spiders) were 
selected for this study due to their abundance in the wild. Both spiders have the 
ability to perform precise and complex behaviours: A. diadematus whilst webbuilding 
and P. agrestis whilst hunting prey, these behaviours are relatively easy to record by 
either filming or phtotgraphy (Peters & Witt, 1949; Witt & Reed, 1965; Witt, 1971; 
Reed, Witt & Scarboro, 1982; Noever, Cronise & Relwani, 1995; Hesselberg & 
Vollrath, 2004; Wyman, Rodenhouse & Bank, 2011; Benamú et al., 2013). Although 
both species are common and abundant predators, they utilise very different 
mechanisms to capture prey. P. agrestis are ground active, visually locating and 
‘pouncing’ on prey (Hardman & Turnbull, 1980; Shaw, Waddicor & Langan, 2005) 
whilst A. diadematus are orb-weaving spiders that spin highly sophisticated and 
intricate webs (Witt, Reed & Peakall, 1968) based on only a few rudimentary rules 
(Krink & Vollrath, 1997).  
There is a lack of literature concerning chemical testing of ground active species, as 
such, we will attempt to assess the plasticity of P. agrestis as a model system and 
whether its sensitivity is comparable to that of A. diadematus with the administration 
of mephedrone (1b). We also aim to establish whether 4-TFMMC (2) and/or 
mephedrone (1b) are biologically active in an orb-weaver system using a developed 
protocol. For P. agrestis we will record if there are any changes in how each leg moves 
in response to stimuli (prey items) with a focus on velocity of the capture legs and 
mean leg rotation (amplitude) with the administration of mephedrone (1b). For A. 
diadematus we will measure specific web parameters such as capture spiral height, 
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number of radii and number of spiral threads (Zschokke, 2011) to see whether 
mephedrone (1b) or 4-TFMMC (2) administration affects one or more of the analysed 
web features.  
Methods  
Experimental design  
Collection and Housing  
Orb-weavers  
A. diadematus were collected by hand exclusively from gorse bushes (Ulex sp.) from 
Ribble Estuary (53.7112° N, 2.9642° W). Only females were used after being allowed 
to acclimatise to lab conditions (25 ±1 ˚C, 44 ± 5% relative humidity, 16:8 D:N) for 14 
days before being dosed. Orb-weavers were individually housed in frames with 
removable side panels (30x5.5x30 cm, LxWxH) constructed from clear acrylic plastic. 
Both side panels (30x30 cm) were coated in a thin layer of petroleum jelly to ensure 
that the webs would not adhere to them during web construction. During the data 
recording period webs were photographed in the afternoon, sprayed and then left 
for 10 minutes to allow spiders to ingest droplets from the silk. Spiders were fed once 
a week, with 6-8 winged prey items (Drosophila melanogaster).  
Wolf Spiders  
Pardosa agrestis were selected due to their abundance in the wild and were collected 
from the same location as the orb-weavers using pitfall traps and by hand. Both male 
and female spiders were collected initially with the intent of having a 1:1 male to 
female ratio but since male mortality was so high, only female wolf spiders were used 
in the experiment. The wolf spiders were individually housed in pots (5x5x7 cm, 
LxWxH) and only mature females without egg sacs were used after being allowed to 
acclimatise to lab conditions (25 ±1 ˚C, 44 ± 5% relative humidity, 12:12 D:N) for at 
least 14 days. The wolf spiders were starved for seven days before being filmed in a 
5.5 cm petri dish. During each filming period spiders were offered two wingless prey 
items (D. melanogaster). Each spider was filmed twice, once prior to dosing and then 
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again seven days later. The spiders were starved again before being dosed and filmed 
on the second occasion. Filming took place at the same time on each day of filming 
under the same temperature, humidity, and lighting conditions to ensure that this did 
not affect hunting behaviour. Due to the drug being passively ingested the amounts 
were too small to be measured accurately.   
Dosing and Drug Solutions:  
Orb-weavers  
Before dosing, the spiders were carefully removed from their webs to be weighed; 
they were then placed back onto their webs and allowed to settle for 30 minutes 
before being dosed. 50 mmol drug solutions were made by dissolving the compounds 
in sugar solution composed of 1.5 g d-Fructose per 5 ml distilled water to ensure 
ready uptake of the drug (Hesselberg & Vollrath, 2004). The solutions were 
administered via a blunt syringe (Witt, 1971) with each spider receiving a single 
droplet (approx. 0.05 cm3). After another 30 minutes, the spiders were weighed again 
to approximate uptake of the drug solution by percentage body mass. A. diadematus 
generally spin new webs every morning but are reluctant to do so unless the web has 
been compromised in some way (i.e. in the case of prey capture or voluntary 
ingestion after spraying with water). To ensure that the spiders built new webs each 
day that were representative of their drugged state, they were partially destroyed 
using a pyrography tool (Zschokke & Herberstein, 2005). Approximately 70% of the 
web was destroyed, taking care to leave the majority of the structural silk intact as 
destruction of too much has been shown to affect some aspects of the web (Zschokke 
& Vollrath, 2000). The silk debris was then left in the frame for the spider to ingest, 
as a normal part of web building includes destruction of the web and ingestion of the 
silk before a new web is spun (Witt & Reed, 1965).  
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Wolf Spiders  
The dosing arena was composed of an inverted 5.5 cm petri dish with a 5.5 cm filter 
paper placed in the lid, soaked in 1.2 ml of 50 mmol drug solution made with distilled 
water (Hanna and Hanna, 2013). A dosage of 100 mmol was initially trialled but 
proved to be fatal so the dosage was lowered to 50 mmol to ensure only sub-lethal 
effects on the spiders were observed. The spiders were left for 25 minutes to allow 
them to passively ingest the drug via their natural grooming behaviour before being 
filmed. 
Data Collection: 
Orb-weavers  
Photography:  
Webs were photographed against a black backdrop with a Canon EOS 700D digital 
camera using a EF-S 18-135 mm f/3.5-5.6 IS STM lens. Speed-lights were positioned 
at either side of the frames to illuminate the web; the following settings gave 
consistently clear images: ISO: 200-400; aperture: 4.5; shutter-speed: 1/320. After 
the web was photographed it was misted and left for 10 minutes and then partially 
destroyed with the pyrography tool. The images were processed using ImageJ 
(Schindelin et al., 2015) where measurements could be taken digitally (Fig. 1) with a 
set scale to calculate the desired web metrics (Table 1).  
Measurements taken on ImageJ were split into ‘web-spiral’ metrics, defined as 
measurements that required a spiral or orb web, and ‘non-web’ metrics defined as 
measurements that could be recorded without a conventional web structure being 
produced. The web-spiral metrics investigated in this study were as follows: average 
cell height; eccentricity; capture spiral area; and free zone area. The non-web metrics 
were: number of hubs a spider created; the total number of radii in a structure; and 
the percentage of perfect radii spun.  
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Fig. 1. Diagram of typical A. diadematus web features (blue) including metrics used to 
calculate eccentricity (yellow) and average mesh height (green).  
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Table 1. Definitions of web and non-web metrics analysed.  
Average cell 
height (cm)  
Approximate  
height of a cell in 
the capture spiral, 
a trapezoid shape 
created by two 
web radii and two 
strands of sticky 
capture silk.  
1 𝑟𝑢 −𝐻𝑟𝑢 𝑟𝑙 −𝐻𝑟𝑙 
 (− )  
2 𝑆𝑢 −1 𝑆𝑙 − 1 
Where:  
𝑟𝑢 – upper vertical capture spiral length  
𝑟𝑙 – lower vertical capture spiral length  
𝐻𝑟𝑢 – upper vertical length of hub and free zone  
𝐻𝑟𝑙 – Lower vertical length of hub and free zone 
𝑆𝑢 – total number of capture spiral turns in the 
upper vertical sector  
𝑆𝑙 – total number of capture spiral turns in the 
lower vertical sector[1]  
Mean capture 
spiral area (cm2)  
Average area of the capture spiral of a web excluding the free zone and 
the hub.  
Eccentricity  A measure of web 
shape, can be 
used to gauge the 
normality of a 
web. A more 
positive value 
would indicate a 
more normal web 
and vice versa.   
√1 − (
𝑤𝑖𝑑𝑡ℎ
ℎ𝑒𝑖𝑔ℎ𝑡
)
2
 
Where:  
𝑤𝑖𝑑𝑡ℎ - horizontal diameter of capture spiral 
ℎ𝑒𝑖𝑔ℎ𝑡 – vertical diameter of capture spiral  
* If the width > height then the bracketed term 
was inverted and eccentricity assigned as a 
negative value[1]  
Free zone area 
(cm2)  
The area free of silk between the capture spiral and the hub, excluding 
the hub area.  
Number of hubs  The total amount of hub-like structures a spider constructed.  
Total Radii  The sum of all radii within a web.  
Perfect radii (%)  Undisrupted radii per web as a percentage of total radii. Distorted 
(‘not-perfect’) radii were defined as any radii which split into a ‘Y’ 
shape or curved more than 5˚ within the capture spiral.  
[1] (Herberstein & Tso, 2000)  
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Wolf Spiders  
High-speed video analysis:  
Wolf spiders were individually placed in a transparent 5.5 cm petri dish with two 
wingless prey items. The dish was placed on a glass table and lit from below using a 
bright infrared light panel (LEDW-BL-400/200-SLLUB-Q-1R-24V, PHLOX). Videoing 
took place in an artificially lit room to reduce the effects of diminished lighting on 
hunting behaviour (Baatrup and Bayley, 1993). A filming session generally lasted 1015 
minutes, unless a spider caught the two prey items in quick succession. The spiders 
were videoed from above using a digital high-speed video camera (Phantom Miro 
ex2) recording at 200 frames per second with a shutter speed of 1 ms and a resolution 
of 640×480 pixels. Two clips were recorded for each spider by manual trigger: one 
clip per prey item capture. A total of 24 clips were recorded, and each one was 
trimmed to contain only the capture movements of the spider-generally 30-80 
frames. The clips were then manually analysed using Manual Whisker Annotator 
(MWA; Hewitt, Yap & Grant, 2016), where each leg was treated as a whisker. Clips 
containing locomotory movements were also initially considered for analysis but 
unfortunately were not consistent enough across the sample to quantify. Using 
MWA, we could track the movement of each individual leg angle frame by frame. For 
each clip analysed the angle of the legs was determined using the centre line of the 
spider and the point marking the end of each leg (Fig. 2). The centre line was 
determined by the placement of a nose and orientation point marked in each tracking 
frame. Once the angle (θ) of each leg had been found angular velocity, defined as the 
speed at which a leg moves throughout the duration of a clip, could be calculated. 
This was done by smoothing the angle signal and then finding the nearest peak from 
the unsmoothed signal to identify the protraction/retraction cycles, though only 
protraction is discussed in this study. As both the leg angles and the 
protraction/retraction cycles had been established, maximum amplitude (˚), defined 
as the scope of movement of a leg throughout the duration of a clip, could then be 
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calculated. This was done by calculating the difference in leg angle between the 
beginning and the end of a movement cycle.  
 
Fig. 2. Video data with overlaid leg tracking (a) showing the three points per leg as well as 
the nose point (yellow); the orientation point (white); and the prey item marker (pale 
brown). Analysis of individual leg angle (b) with legs highlighted (blue) as well as each leg tip 
(yellow). The centre line is marked (yellow) and has been artificially extended (red) to 
visually demonstrate how mean leg angle (θ) is calculated by the software (MWA).  
Data Analysis:  
Statistical comparisons between the effects of the drug treatments on web shape 
versus the control were made using a one-way ANOVA or a Kruskal-Wallis test 
followed by Tukey post hoc tests depending on the data distributions. Wilcoxon 
signed-rank tests were used to test prey capture variables of the wolf spiders. 
Comparisons of web building frequency versus shape were calculated using a 
chisquared test. All statistical tests were carried out using the software R v3.4.1 (R 
Development Core Team, 2012).  
 
 
 
( a )   ( b )   
θ   
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Results  
Orb-weavers  
Mortality rate was low over the course of the experiment, with only one casualty in 
the 4-TFMMC (2) group on day 2. One spider was also excluded from this group as it 
did not ingest the drug solution, this resulted in 7 spiders being used in the 4-TFMMC  
(2) treatment group.  
The effects of mephedrone (1b) and 4-TFMMC (2) on web geometry are summarised 
in Table 2. A chi-squared test shows the total counts of web shapes across the whole 
test period. Mephedrone (1b) dosed spiders spun more illegible webs than expected, 
whilst the control and 4-TFMMC (2) treated spiders spun no illegible webs (Fig. 3). 
Mephedrone (1b) dosed spiders also spun less scaffold and corner webs than the 
other two groups, suggesting that ingestion of the drug has a significant effect on web 
geometry (X-squared=22.265, df = 3, p-value = 0.001).  
Table 2. Observed Frequencies of web shape vs. treatment for the orb-weaving spiders across 
all days analysed.  
Treatment  1. Spiral  2. Illegible  3. Scaffold  4. Corner  
Control  26  0  1  6  
4-TFMMC  25  0  0  3  
Mephedrone  23  6  4  0  
Ingestion of the sugar solutions was not consistent between treatments (Fig. 4) with 
both drugged sugar solutions having a lower uptake than the control (11.63% ±se 
0.01). As Hesselberg and Vollrath (2004) suggested, this may imply that the spiders 
could detect the drugs in the solution and that they may have had an unpleasant 
taste, 4-TFMMC (2; 5.87% ±se 0.01) even more so than mephedrone (1b; 9.28% ±se 
<0.001). It is possible that if a sweeter solution had been used then uptake may have 
been higher, though then problems with the solubility of the drug in the more 
saturated solution would have become an issue (Hesselberg & Vollrath, 2004).  
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Fig. 3. Web categories based on their overall appearance: Spiral, where a capture spiral was 
visible; Illegible, where no meaningful measurements could be taken from the web due to its 
highly disjointed nature; Scaffold, where some structural silk was present, but no capture 
spiral; and Corner, where the spider had created a structure in the corner of a frame that 
could not be considered illegible or as structural silk.   
 
. Scaffold 3   
1 . Spiral   
4 . Corner   
2 . Illegible   
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Fig. 4. Mean amount (±se) of sugar solution ingested by A. diadematus calculated as a 
percentage of bodyweight for all three treatments. The control treatment refers to a control 
sugar solution containing no drug.  
Spiders dosed with mephedrone (1b) spun significantly less perfect radii than the 
controls and 4-TFMMC (2) dosed spiders on day 2 (Chi=6.71, p= 0.035, df= 2; Fig. 5). 
There was an upward pattern towards more perfect radii for the mephedrone (1b) 
dosed spiders over the course of the study; on day 16 the percentage of perfect radii 
of mephedrone (1b) treated spider was similar to controls. Although not significant, 
mephedrone (1b) spiders also spun more hubs on day 16 (Chi= 5.84, p=0.054) than 
the control and 4-TFMMC (2). There were no differences in the total number of radii 
spun between treatments across the recording period (Table S.I-2.0).  
For the web-spiral metrics only capture spiral area and free zone area were found to 
show significant differences between treatments (Fig. 6; Table S.I-2.0). Free zone area 
was significantly smaller on day 2 for the mephedrone dosed spiders (1b; f=7.814, 
p=0.008, df=2) when compared to the control and 4-TFMMC (2) dosed spiders. There 
was also a significant reduction in free zone area for the mephedrone webs on day 4 
(1b; f=3.663, p=0.049, df=2) though the post hoc test reported no significant 
difference between groups. The observed increase in free zone area across the 
recording period indicates that this aspect of the webs, for the mephedrone dosed 
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spiders, slowly became more regular. Throughout the study capture spiral area 
remained consistently small for the mephedrone (1b) treated spiders, with no 
apparent recovery to control levels. Although consistently smaller, only the webs 
spun by the mephedrone (1b) spiders on day 8 showed a significant reduction in 
capture spiral area compared to the control and 4-TFMMC (2, f=4.437, p=0.027, df=  
2).  
  
Fig. 5. Mean (±se) of non-web metrics across the four recording periods. Plots depict 
(topbottom) mean number of hubs; mean total radii; mean percentage perfect radii across 
all treatments: control (C), 4-TFMMC (2; F), and mephedrone (1b; M).  
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Fig. 6. Mean (±se) of web-spiral metrics depicting (L-R): mean average cell height (cm); mean 
capture spiral area (cm2); mean eccentricity; mean free zone area (cm2) across all treatments: 
control (C), 4-TFMMC (2; F), and mephedrone (1b; M).  
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Wolf Spiders  
A week after the spiders were treated and filmed only one of the mephedrone dosed 
wolf spiders had died. Although all three prey capture metrics show a reduction after 
mephedrone administration, only the maximum amplitude of the capture legs was 
significantly reduced compared to controls (W=1153, p=0.001; Fig. 7; Table S.I-3.0).  
  
Fig. 7. Mean (±se) of maximum amplitude (˚) for both capture (blue) and back (orange) legs, 
velocity (mm/sec) for the capture legs (blue) of the wolf spiders treated with either a control 
sugar solution (C), or a mephedrone dosed sugar solution (1b; M). 
Discussion  
This study investigated the effects of mephedrone (1b) and 4-TFMMC (2) on 
webbuilding in A. diadematus. Whilst the effects of 4-TFMMC (2) were not 
significantly different to controls, it was found that mephedrone (1b) significantly 
altered webs metrics. Recovery after 16 days was witnessed but not in all measured 
web metrics. We also aimed to test the plasticity of prey capture metrics in P. agrestis 
after administration of mephedrone (1b) as an alternative system to web-based 
chemical testing. It was found that the synthetic cathinone did have a significant 
effect on the capture metrics of P. agrestis, suggesting that it is a viable system for 
testing behavioural impairment.  
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Orb-weavers  
Though webs were generally similar within treatment groups, individual variation 
occurred from spider to spider. Despite web-building being carried out in a very 
formulaic manner (Foelix, 2011), it is well known that the spinning habits of A. 
diadematus vary depending on numerous circumstances such as age, weight, where 
previous structural silk has been placed; temperature; and humidity (Witt, Reed & 
Peakall, 1968; Vollrath, Downes & Krackow, 1997). These biotic and abiotic factors 
can affect how a web is spun and thus its geometry. Some drugged individuals in the 
current study spun webs that resembled those of the control group, despite having 
ingested a similar amount of solution as a drugged spider that produced an illegible 
web. Despite this intragroup variation, the results of this study generally align with 
previous work with regards to the expected effects of mephedrone (1b) being similar 
to d-amphetamine (Witt & Reed, 1965; Reed, Witt & Scarboro, 1982; Hesselberg & 
Vollrath, 2004) in so much as that a trend towards smaller webs and reduced building 
frequency was observed.  
Witt and Reed (1965) reviewed the effects of drug application on web-spinning 
behaviour and reported that methamphetamine increases building frequency and 
web size, a compound which arguably is more structurally similar to mephedrone (1b) 
than d-amphetamine. The reported effects of methamphetamine are actually more 
similar to what was observed when dosing spiders with 4-TFMMC (2); though not 
statistically significant, the individuals given 4-TFMMC (2) spun more uniform webs 
than the control on days 2 and 4. It should be noted however, that these similarities 
could simply be as a result of the decreased ingestion of the 4-TFMMC (2) solution 
having less of an effect on web-building (Reed & Witt, 1968). As well as the reduced 
dosage, the effects of the 4-TFMMC (2) in comparison to mephedrone (1b) could have 
arisen as a result of 4-TFMMC (2) being metabolised more rapidly than mephedrone 
(1b) and/or being metabolically unavailable in this particular spider system.  
It was feared that the spiders would reject the drugged sugar solutions administered 
via syringe as they would when given distilled water in the same manner but it seems 
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that A. diadematus are more inclined to take a sweetened solution of water even 
when it contains a foreign substance. Studies have been carried out wherein spiders 
were starved of water prior to dosing to ensure ready uptake of the solution (Samu 
and Vollrath, 1992), though this option was not pursued as we did not want to risk 
desiccation of the subjects; as the spiders were only fed once a week and derive most 
of their liquid uptake from flies, it was feared that a significant loss of body mass 
might occur and affect the quality of the webs (Zschokke & Herberstein, 2005). The 
dose of mephedrone (1b) administered to the spiders, with an average uptake of 
9.28%, was sufficient enough to have an effect on web spinning. The uptake of 
4TFMMC (2) was considerably lower (5.87%) and compared to the control uptake 
(11.63%) suggests that the drug could be detected and potentially that it has a more 
noticeable taste than mephedrone (1b). The dosages of the drug solutions used in 
this paper were selected to be analogous to that of a human dose, as it was 
discovered that A. diadematus are surprisingly resistant to high doses of 
amphetamine type compounds (Witt, 1971).   
The effects of a high dose of amphetamine (Witt & Reed, 1965; Hesselberg & Vollrath, 
2004) are comparable to those seen when a spider was dosed with mephedrone (1b) 
in the current study, with smaller capture spirals and free zones being spun. During 
the recovery period, the area of the free zone steadily increased but capture spiral 
area remained at a diminished size for the remainder of the study, though this may 
be as a result of A. diadematus often building within the constraints of any previously 
laid structural silk (Zschokke & Vollrath, 2000). These observed patterns would 
suggest that mephedrone (1b) affects the sensory control of the spider, similarly to 
amphetamine (Peters, Witt, & Wolff, 1950). Visual observation approximately 20 
minutes after administration of the drugged sugar solution appears to support this 
conclusion, with spiders observed hanging from their webs reaching for empty space 
whilst spinning and twitching sporadically. This effect was also noticed in the spiders’ 
behaviour when they were reweighed, seeming more sluggish and less inclined to 
leave weighing pots. By day 8 there was a large change in web eccentricity of the 
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mephedrone (1b) webs, with spiders in this treatment group producing less eccentric 
webs (expressed as more positive values). This likely indicates a recovery from the 
mephedrone (1b) drugging at this time, expressed as the free zone area and the 
eccentricity returning to similar values compared to the controls. Conversely, average 
mesh size remains relatively consistent throughout the experiment regardless of 
treatment, possibly suggesting that it is not affected by reduced sensory control at 
these doses. The large value on day 16 for the mephedrone (1b)  dosed spiders being 
the exception, resulting from several of the more severely affected spiders beginning 
to spin disjointed but interpretable spiral shaped webs, instead of illegible structures 
that prohibited the measurement of spiral metrics.  
The non-web metrics recorded provide information on how consistent a web is 
despite not including any information about the capture spiral. For all non-web 
metrics both the control and 4-TFMMC (2) treatments produced very similar values. 
The number of hubs was generally 1 if a spider spun a web, and 0 if not. For the 
percentage of perfect radii, the control and 4-TFMMC (2) treatments consistently 
produced webs with values between 75-100%, with at least 20 radii per web. 
Combined with the results derived from the spiral web metrics, 4-TFMMC (2) dosed 
spiders spun webs that did not statistically deviate from the control group webs at a 
50 mmol dosage. On the other hand, the webs spun by spiders dosed with 
mephedrone (1b) often contained multiple hubs per structure, with those structures 
recorded as illegible until recovery and production of more consistent spirals towards 
the end of the study. Multiple hubs was a unexpected and novel phenomenon that 
has not been reported in previous studies discussing the administration of 
psychoactive substances to A. diadematus (Peters & Witt, 1949; Witt & Reed, 1965; 
Witt, 1971; Reed, Witt & Scarboro, 1982; Noever, Cronise & Relwani, 1995; 
Hesselberg & Vollrath, 2004). The author speculates that multiple hubs may have 
arisen due to the sensory disorientation of the spiders, though it should be noted that 
its occurrence persisted throughout the study despite the percentage of perfect radii 
and the total number of radii showing a general trend towards recovery.  
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Wolf Spiders  
As ground active spiders would not accept sugar droplets from a syringe, the drug 
solution was administered passively to P. agrestis following the methodology of 
Hanna and Hanna (2013). Coating prey items was considered as an alternative but 
prey could not be dosed without killing them and dead prey items were ignored by 
the wolf spiders, likely due to these visual hunters requiring prey movement for 
detection (Ford, 1978). Passive ingestion does appear to be an effective way to dose 
P. agrestis, though it is limited in its use due to the inability to calculate the exact 
dose ingested, as such it is more suitable for studies trying to assess contact dosage 
rather than the ingestion of compounds.   
Administering mephedrone (1b) to P. agrestis significantly reduces capture leg 
movement during prey capture with a significant decrease in the maximum amplitude 
of capture legs after dosing, meaning a smaller arc of movement when compared to 
pre-drug controls. Although this pattern was similar in non-capture (back) legs the 
difference was not significant. Visual observations after dosing showed spiders 
exhibiting less exploratory behaviour, often only pouncing on prey items when they 
came into contact with the subject. There was also a slight decrease in the velocity of 
the capture legs but this result was not significant. If we assume that mephedrone 
(1b) has a similar effect on P. agrestis as A. diadematus, this could suggest that 
protraction velocity of the capture legs is not affected by sensory disruption or 
potentially that the speed at which the legs extend towards the prey is predetermined 
by the spider’s individual physiology (Casas, Steinmann & Dangles, 2008). All spiders 
filmed caught both prey items offered, even with seemingly reduced mobility, 
indicating that appetite was not affected by the drug. This conclusion is in agreement 
with research carried out on wolf spiders exposed to cypermethrin that showed no 
effect on appetite despite suffering from locomotory sub-lethal effects (Shaw, 
Waddicor & Langan, 2005).  
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Conclusion  
The administration of mephedrone (1b) had significant effects on the behaviours of 
both A. diadematus and P. agrestis. The latter shows promise as a novel system that 
could be used in behavioural drug studies. We recorded novel behaviour in the form 
of multiple hubs for dosed orb-weaving spiders and we also identified recovery of 
some, but not all, web metrics after day 16 of the study. The administration of 
4TFMMC (2) did not have any significant effects on web building in A. diadematus at 
the given dosage (50 mmol). It is suggested that the effects of mephedrone (1b) on 
P. agrestis and A. diadematus are similar from the perspective of reduced movement 
and exploratory behaviour, though this link is only made tenuously with the 
knowledge that more in-depth analysis of the P. agrestis system is required. Using P. 
agrestis as a behavioural drug testing system does seem like a viable 
optionparticularly if using orb-weaving spiders is not feasible due to availability of lab 
resources or geographical restrictions, though the author suggests finding a more 
effective and quantifiable route of drug application. The present study was not 
designed to establish the effects the compounds would have on a spider’s CNS, as 
such, an interesting extension of this research would be to examine the effects of 
novel synthetic cathinones on invertebrate neurobiology to further explore the 
mechanisms that drive the changes in behaviour.  
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Chapter 4 
Concluding Remarks  
Organic Synthesis  
Previous work by Khreit et al. (2013) reported the synthesis and characterisation of 
4-TFMMC (2); here we report the successful synthesis and characterisation of its 
novel metabolites: R.4-TFMMC (3), 4-TFMC (4), and R.4-TFMC (5). The author 
suggests that tenuous identification of the compounds using presumptive tests is 
possible and that all four compounds can be separately identified using 13C NMR, 
though further work will need to be carried out to verify if separation and 
identification is possible from a mixture. Future work also includes developing a 
chromatographic method for the separation of the four compounds using a 
HILICbased column to aid in potential identification of samples by analytical bodies. 
The synthesis and characterisation of other metabolites of 4-TFMMC (2; Khreit et al., 
2013) and NPS’ is also an interesting prospect when considering the fast-paced nature 
of the NPS market.  
Animal Behaviour  
The effects that mephedrone (1b) had on the webs of A. diadematus broadly agree 
with literature discussing d-amphetamine in the same system (Witt & Reed, 1965; 
Reed, Witt & Scarboro, 1982; Hesselberg & Vollrath, 2004). 4-TFMMC (2) had no 
significant effect on the webs but future work should include the trial of a sweeter 
solution to see if percentage ingestion and/or the effect of the drug on the system 
increases. The filming of the webs during construction (Hesselberg & Vollrath, 2004) 
and resulting time budgets would also be an ideal way to see if the drugs had any 
effects on the spiders that weren’t reflected in the webs they produced. This 
technique could also be used to try and reveal the reasons behind occurrences such 
as multiple hubs and the how illegible webs were spun. Future work concerning the 
effects of mephedrone (1b) and 4-TFMMC (2) on the CNS’ of the two spider models 
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would also aid in the understanding of exactly how the recorded behaviours were 
affected.  
No previous work has been done using P. agrestis as a behavioural drug model, 
though this thesis establishes that they have the potential once a robust protocol has 
been put in place to not only evaluate metrics associated with hunting, but 
locomotory behaviours too. In addition, further investigation should be done into 
how to accurately quantify the amount of drug the spider ingests. Whether this would 
entail an adjustment of Hanna and Hanna’s (2013) methodology, which was used to 
assess passive pesticide dosage, or dosage by some other means.  
For studies carried out over a longer period of time, the author recommends using 
spiders bred within the lab to help eliminate environmental variation that may 
otherwise be present. It should be noted however, that it is a time-consuming process 
with a very high spiderling mortality rate (Zschokke & Herberstein, 2005). Once 
further development and refinement of these methods has taken place, the 
possibility for the testing of other compounds within the bounds of the spider 
systems discussed in this study seems like a reasonable next step. In addition to 
further drug testing, investigation into the effects of these substances on a spider’s 
CNS would also aid the comprehensive understanding of how the spider system’s 
behavioural mechanisms are affected.  
 
 
 
 
 
55  
  
References  
Alotaibi, M., Husbands, S. and Blagbrough, I. (2015). 1H, 13C, 15N HMBC, and 19F 
NMR spectroscopic characterisation of seized flephedrone, cut with benzocaine. 
Journal of Pharmaceutical and Biomedical Analysis, 107, pp.535-538.  
Baatrup, E. and Bayley, M. (1993). Quantitative analysis of spider locomotion 
employing computer-automated video tracking. Physiology & Behavior, 54(1), 
pp.8390.  
Benamú, M., Schneider, M., González, A. and Sánchez, N. (2013). Short and long-term 
effects of three neurotoxic insecticides on biological and behavioural attributes of the 
orb-web spider Alpaida veniliae (Araneae, Araneidae): implications for IPM programs. 
Ecotoxicology, 22(7), pp.1155-1164.  
Camilleri, A., Johnston, M., Brennan, M., Davis, S. and Caldicott, D. (2010). Chemical 
analysis of four capsules containing the controlled substance analogues 
4methylmethcathinone, 2-fluoromethamphetamine, α-phthalimidopropiophenone 
and N-ethylcathinone. Forensic Science International, 197(1-3), pp.59-66.  
Capriola, M. (2013). Synthetic cathinone abuse. Clinical Pharmacology: Advances and 
Applications, pp.109.  
Casas, J., Steinmann, T. and Dangles, O. (2008). The Aerodynamic Signature of 
Running Spiders. PLoS ONE, 3(5), pp.2116.  
Cattaneo, A., Gornati, R., Chiriva-Internati, M. and Bernardini, G. (2009). 
Ecotoxicology of nanomaterials: the role of invertebrate testing. Invertebrate Survival 
Journal, 6, pp.79-97.  
Christie, R., Horan, E., Fox, J., O'Donnell, C., Byrne, H., McDermott, S., Power, J. and 
Kavanagh, P. (2013). Discrimination of cathinone regioisomers, sold as ‘legal highs’, 
by Raman spectroscopy. Drug Testing and Analysis, 6(7-8), pp.651-657.  
Dargan, P., Albert, S. and Wood, D. (2010). Mephedrone use and associated adverse 
effects in school and college/university students before the UK legislation change. 
QJM, 103(11), pp.875-879.  
Deluca, P., Davey, Z., Corazza, O., Di Furia, L., Farre, M., Flesland, L., Mannonen, M.,  
Majava, A., Peltoniemi, T., Pasinetti, M., Pezzolesi, C., Scherbaum, N., Siemann, H., 
Skutle, A., Torrens, M., van der Kreeft, P., Iversen, E. and Schifano, F. (2012). 
Identifying emerging trends in recreational drug use; outcomes from the Psychonaut 
Web Mapping Project. Progress in Neuro-Psychopharmacology and Biological 
Psychiatry, 39(2), pp.221-226.  
56  
  
Ellefsen, K., Concheiro, M. and Huestis, M. (2016). Synthetic cathinone 
pharmacokinetics, analytical methods, and toxicological findings from human 
performance and postmortem cases. Drug Metabolism Reviews, 48(2), pp.237-265.  
Every-Palmer, S. (2010). Warning: Legal Synthetic Cannabinoid-Receptor Agonists 
Such As JWH-018 May Precipitate Psychosis in Vulnerable Individuals. Addiction, 
105(10), pp.1859-1860.  
Foelix, R. (2011). Biology of spiders. New York: Oxford University Press.  
Ford, M. (1978). Locomotory activity and the predation strategy of the of the 
wolfspider Pardosa amentata (Clerck) (Lycosidae). Animal Behaviour, 26, pp.31-35.  
Giese, C., Igoe, D., Gibbons, Z., Hurley, C., Stokes, S., McNamara, S., Ennis, O., 
O’Donnell, K., Keenan, E., De Gascun, C., Lyons, F., Ward, M., Danis, K., Glynn, R., 
Waters, A. and Fitzgerald, M. (2015). Injection of new psychoactive substance snow 
blow associated with recently acquired HIV infections among homeless people who 
inject drugs in Dublin, Ireland, 2015. Eurosurveillance, 20(40).  
Hadlock, G., Webb, K., McFadden, L., Chu, P., Ellis, J., Allen, S., Andrenyak, D., 
VieiraBrock, P., German, C., Conrad, K., Hoonakker, A., Gibb, J., Wilkins, D., Hanson, 
G. and Fleckenstein, A. (2011). 4-Methylmethcathinone (Mephedrone): 
Neuropharmacological Effects of a Designer Stimulant of Abuse. Journal of 
Pharmacology and Experimental Therapeutics, 339(2), pp.530-536.  
Hanna, C. and Hanna, C. (2013). Sublethal pesticide exposure disrupts courtship in the 
striped lynx spider,Oxyopes salticus(Araneae: Oxyopidae). Journal of Applied 
Entomology, 138(1-2), pp.141-148.  
Herberstein, M., and Tso, I., (2000), Evaluation of formulae to estimate the capture 
area and mesh height of orb webs (Araneoidea, Araneae). Journal of Arachnology, 
28(2), pp.180-184.  
Hesselberg, T. and Vollrath, F. (2004). The effects of neurotoxins on web-geometry 
and web-building behaviour in Araneus diadematus Cl. Physiology & Behavior, 82(23), 
pp.519-529.  
Hewitt B, Hoon Yap M, Grant RA (2016) Manual whisker annotator (MWA): a modular 
open source tool. J Open Res Soft 4:e16. doi:10.5334/jors.93  
James, D., Adams, R., Spears, R., Cooper, G., Lupton, D., Thompson, J. and Thomas, S. 
(2010). Clinical characteristics of mephedrone toxicity reported to the UK National 
Poisons Information Service. Emergency Medicine Journal, 28(8), pp.686-689.  
57  
  
Kalendra, D. and Sickles, B. (2003). Diminished Reactivity of Ortho-Substituted 
Phenacyl Bromides toward Nucleophilic Displacement. The Journal of Organic 
Chemistry, 68(4), pp.1594-1596.  
Kalix P, Braenden O. (1985). Pharmacological aspects of the chewing of khat leaves. 
Pharmacol Rev., 37(2), pp.149–164.  
Khreit, O., Grant, M., Zhang, T., Henderson, C., Watson, D. and Sutcliffe, O. (2013). 
Elucidation of the Phase I and Phase II metabolic pathways of (±)-
4′methylmethcathinone (4-MMC) and (±)-4′-(trifluoromethyl)methcathinone 
(4TFMMC) in rat liver hepatocytes using LC–MS and LC–MS2. Journal of 
Pharmaceutical and Biomedical Analysis, 72, pp.177-185.  
Krink, T. and Vollrath, F. (1997). Analysing Spider Web-building Behaviour with 
Rulebased Simulations and Genetic Algorithms. Journal of Theoretical Biology, 185(3), 
pp.321-331.  
New psychoactive substances in Europe. An update from the EU Early Warning 
System (March 2015), 2015  
Nigg, H. and Seigler, D. (2013). Phytochemical resources for medicine and agriculture. 
New York: Springer Science+Business Media, LLC.  
Noever, R., Cronise J., and Relwani R. A. (1995). Using spider-web patterns to 
determine toxicity. NASA Tech Briefs, 19(4), pp.82.  
Nutt, D., King, L., Saulsbury, W. and Blakemore, C. (2007). Development of a rational 
scale to assess the harm of drugs of potential misuse. The Lancet, 369(9566), pp.1047-
1053.  
Pasquet, A., Tupinier, N., Mazzia, C. and Capowiez, Y. (2015). Exposure to spinosad 
affects orb-web spider (Agalenatea redii) survival, web construction and prey capture 
under laboratory conditions. Journal of Pest Science, 89(2), pp.507-515.  
Peters, H. and Witt, P. (1949). Die Wirkung von Substanzen auf den Netzbau der 
Spinnen. Experientia, 5(4), pp.161-162.  
Peters, H., Witt, P. and Wolff, D. (1950). Die Beeinflussung des Netzbaues der Spinnen 
durch neurotrope Substanzen. Zeitschrift für Vergleichende Physiologie, 32(1-2), 
pp.29-45.  
Pozo, O., Ibanez, M., Sancho, J., Lahoz-Beneytez, J., Farre, M., Papaseit, E., de la Torre, 
R. and Hernandez, F. (2015). Mass Spectrometric Evaluation of Mephedrone In Vivo 
Human Metabolism: Identification of Phase I and Phase II Metabolites, Including a 
Novel Succinyl Conjugate. Drug Metabolism and Disposition, 43(2), pp.248-257.  
58  
  
R Development Core Team, 2012. R: A Language and Environment for Statistical 
Computing. R Foundation for Statistical Computing, Vienna, Austria.  
Reed, C. and Witt, P. (1968). Progressive disturbance of spider web geometry caused 
by two sedative drugs. Physiology & Behavior, 3(1), pp.119-124.  
Reed, C., Witt, P. and Scarboro, M. (1982). Maturation and-amphetamine-induced 
changes in web building. Developmental Psychobiology, 15(1), pp.61-70.  
Samu, F. and Vollrath, F. (1992). Spider orb web as bioassay for pesticide side effects. 
Entomologia Experimentalis et Applicata, 62(2), pp.117-124.  
Santali, E., Cadogan, A., Daeid, N., Savage, K. and Sutcliffe, O. (2011). Synthesis, full 
chemical characterisation and development of validated methods for the 
quantification of (±)-4′-methylmethcathinone (mephedrone): A new “legal high”. 
Journal of Pharmaceutical and Biomedical Analysis, 56(2), pp.246-255.  
Schifano, F., Albanese, A., Fergus, S., Stair, J., Deluca, P., Corazza, O., Davey, Z., 
Corkery, J., Siemann, H., Scherbaum, N., Farre’, M., Torrens, M., Demetrovics, Z. and 
Ghodse, A. (2011). Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, 
pharmacological and clinical issues. Psychopharmacology, 214(3), pp.593-602.  
Schindelin, J., Rueden, C., Hiner, M. and Eliceiri, K. (2015). The ImageJ ecosystem: An 
open platform for biomedical image analysis. Molecular Reproduction and 
Development, 82(7-8), pp.518-529.  
Shaw, E., Waddicor, M. and Langan, A. (2005). Impact of cypermethrin on feeding 
behaviour and mortality of the spider Pardosa amentata in arenas with artificial 
‘vegetation’. Pest Management Science, 62(1), pp.64-68.  
The Misuse of Drugs Act 1971 (Amendment) Order 2008. S.I. 2009/3130 The Misuse 
of Drugs Act 1971 (Modification) (No. 2) Order 2003. S.I. 2004/3201 The Misuse of 
Drugs Regulations 2001. S.I. 2002/3998  
Toole K., Fu S., Shimmon R., Kraymen N. (2012). Color Tests for the Preliminary 
Identification of Methcathinone and Analogues of Methcathinone. Microgram 
Journal. 9 (1), pp.27–32.  
UK Government, (1971). Misuse of Drugs Act.  
UK Government, (2016). Psychoactive Substances Act.  
United Nations Office on Drugs and Crime (2015). Recommended methods for the 
Identification and Analysis of Synthetic Cathinones in Seized Materials. New York: 
Laboratory and Scientific Section.  
59  
  
United Nations Office on Drugs and Crime (UNODC) (1989). Chemistry and Reaction 
Mechanisms of Rapid Tests for Drugs of Abuse and Precursors Chemicals. Federal 
Republic of Germany: University of Tübingen: Pharmaceutical Institute.  
United Nations Office on Drugs and Crime (UNODC) (1994). Rapid Testing Methods of 
Drugs of Abuse. New York: Laboratory and Scientific Section.  
United Nations Office on Drugs and Crime (UNODC) (2005). Colour Tests for Precursor 
Chemicals of Amphetamine-Type Substances. The Use of Colour Tests for 
Distinguishing between Ephedrine-Derivatives. Hungary: Szeged University, 
Department of Pharmacognosy  
United Nations Office on Drugs and Crime (UNODC) (2013). World Drug Report 2013. 
United Nations publication. Vienna  
Vardakou, I., Pistos, C. and Spiliopoulou, C. (2011). Drugs for youth via Internet and 
the example of mephedrone. Toxicology Letters, 201(3), pp.191-195.  
Vollrath, F., Downes, M. and Krackow, S. (1997). Design Variability in Web Geometry 
of an Orb-Weaving Spider. Physiology & Behavior, 62(4), pp.735-743.  
Wastnedge, E. (2014). Legal highs: the drugs that are causing heroin addicts to eat 
themselves. Drugs and Alcohol Today, 14(4).  
Winstock, A., Mitcheson, L., Deluca, P., Davey, Z., Corazza, O. and Schifano, F. (2010). 
Mephedrone, new kid for the chop?. Addiction, 106(1), pp.154-161.  
Witt, P. (1971). Drugs alter web-building of spiders: A review and evaluation. 
Behavioral Science, 16(1), pp.98-113.  
Witt, P. (1971). Instructions for Working with Web-Building Spiders in the Laboratory. 
BioScience, 21(1), pp.23-25.  
Witt, P. and Reed, C. (1965). Spider-Web Building. Science, 149(3689), pp.1190-1197.  
Witt, P., Reed, C. and Peakall, D. (1968). A Spider's Web. Berlin, Heidelberg: Springer 
Berlin Heidelberg.  
Wubbels, G., Winitz, S. and Whitaker, C. (1990). NMR and ultraviolet spectral 
characterization of dihydrobenzene intermediates in the displacement of hydrogen 
by intramolecular nucleophilic aromatic photosubstitution. The Journal of Organic 
Chemistry, 55(2), pp.631-636.  
Wyman, K., Rodenhouse, N. and Bank, M. (2011). Mercury bioaccumulation, 
speciation, and influence on web structure in orb-weaving spiders from a forested 
watershed. Environmental Toxicology and Chemistry, 30(8), pp.1873-1878.  
60  
  
Zschokke, S. (2011). Spiral and web asymmetry in the orb webs of Araneus 
diadematus (Araneae: Araneidae). Journal of Arachnology, 39(2), pp.358-362.  
Zschokke, S. and Herberstein, M. (2005). Laboratory Methods for Maintaining and 
Studying Web-building Spiders. Journal of Arachnology, 33(2), pp.205-213.  
Zschokke, S. and Vollrath F. (2000). Planarity and size of orb-webs built by Araneus 
Diadematus (Araneae: Araneidae) under natural and experimental conditions. 
Ekologia Bratislava. 19. pp.307-318.  
     
61  
  
Appendix  
Table SI-1.0 Compound Structure and accurate mass…………………………………..….……62 
Table SI-2.0 Statistical results for A. diadematus……………………………………………………63 
Table SI-3.0 Statistical results for P. agrestis………………………………………………………….63 
Figure SI-1.0 13C NMR Spectrum of 4-TFMMC (2)………………………………………….……..64 
Figure SI-1.1 13C NMR Spectrum of R.4-TFMMC (3)………………………………………………64 
Figure SI-1.2 13C NMR Spectrum of 4-TFMC (4)…………………………………………………….65 
Figure SI-1.3 13C NMR Spectrum of R.4-TFMC (5)………………………………………….………65 
Figure SI-2.0 19F NMR Spectrum of 4-TFMMC (2)………………………………………………….66 
Figure SI-2.1 19F NMR Spectrum of 4-TFMMC (3)………………………………………………….66 
Figure SI-2.2 19F NMR Spectrum of 4-TFMMC (4)………………………………………………….67 
Figure SI-2.3 19F NMR Spectrum of 4-TFMMC (5)………………………………………………....67 
Figure SI-3.0 Gradient enhanced HMBC spectrum of 4-TFMMC (2)……………………....68 
Figure SI-3.1 Gradient enhanced HMBC spectrum of R.4-TFMMC (3)…………………….68 
Figure SI-3.2 Gradient enhanced HMBC spectrum of 4-TFMC (4)…………………..………69 
Figure SI-3.3 Gradient enhanced HMBC spectrum of R.4-TFMC (5)………………………..69 
Figure SI-4.0 Gradient enhanced HMBC with X-decoupling spectrum of 4-TFMMC  
(2)………………………………………………………………………………………………………………….………70 
Figure SI-4.1 Gradient enhanced HMBC with X-decoupling spectrum of R.4-TFMMC 
(3)…………………………………………………………………………………………………………………….…...70 
Figure SI-4.2 Gradient enhanced HMBC with X-decoupling spectrum of 4-TFMC 
(4)………………………………………………………………………………………………………………………....71 
Figure SI-4.3 Gradient enhanced HMBC with X-decoupling spectrum of R.4-TFMC 
(5)…………………………………………………………………………………………………………………....…..71 
Figure SI-5.0 FTIR Spectrum of 4-TFMMC (2)………………………………………………...…......72 
Figure SI-5.1 FTIR Spectrum of R.4-TFMMC (3)………………………………………………………72 
Figure SI-5.2 FTIR Spectrum of 4-TFMC (4)……………………………………………………...…….73 
Figure SI-5.3 FTIR Spectrum of R.4-TFMC (5)………………………………………………………....73 
62  
  
Table SI-1.0 Compound Structure and accurate mass  
Compound 
Name/Number  
Structure  Exact mass 
found  
4-TFMMC/2  
  
232.0949  
R.4-TFMMC/3  
  
234.1108  
4-TFMC/4  
  
218.0793  
R.4-TFMC/5  
 
220.0949  
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Table SI-2.0 Statistical results for A. diadematus   
Table SI-2.0 
        
  Mean & SD for Treatment      
Day Variable Control 4-TFMMC 4-MMC Test Statistic p value Df 
D2 % Perfect Radii 0.72 ±0.44a 0.82 ±0.37a 0.36 ±0.44b Chi 6.709 0.035 2 
D2 Average Cell Height 0.28 ±0.08a 0.26 ±0.08a 0.21 ±0.05a Chi 2.751 0.253 2 
D2 # Hubs 0.63 ±0.52a 0.86 ±0.38a 1.11 ±1.36a Chi 0.641 0.726 2 
D2 # Radii 23.33 ±9.35a 29.17 ±6.49a 21.25 ±11.95a f 1.069 0.372 2 
D2 Free Zone Area 11.25 ±3.58a 12.78 ±4.98a 1.60 ±2.39b f 7.814 0.008 2 
D2 Eccentricity 0.23 ±0.38a 0.31 ±0.39a -0.04 ±0.44a Chi 1.989 0.370 2 
D2 Capture Spiral Area 276.06 ±70.61a 265.30 ±98.51a 157.59 ±92.00a f 1.945 0.189 2 
D4 % Perfect Radii 0.71 ±0.44a 0.92 ±0.17a 0.77 ±0.32a Chi 1.074 0.585 2 
D4 Average Cell Height 0.28 ±0.12a 0.25 ±0.09a 0.22 ±0.10a Chi 0.967 0.617 2 
D4 # Hubs 0.75 ±0.46a 1.14 ±0.38a 0.89 ±0.60a Chi 2.327 0.312 2 
D4 # Radii 29.00 ±6.78a 29.43 ±6.02a 25.00 ±11.24a Chi 0.770 0.681 2 
D4 Free Zone Area 12.61 ±3.65a 11.37 ±4.56a 6.33 ±4.52a f 3.663 0.049 2 
D4 Eccentricity 0.31 ±0.16a 0.24 ±0.33a 0.03 ±0.51a Chi 0.630 0.730 2 
D4 Capture Spiral Area 304.22 ±85.93a 256.55 ±74.03a 186.92 ±90.64a f 3.017 0.077 2 
D8 % Perfect Radii 0.97 ±0.03a 0.94 ±0.10a 0.56 ±0.53a Chi 0.548 0.760 2 
D8 Average Cell Height 0.24 ±0.11a 0.27 ±0.07a 0.18 ±0.04a Chi 4.480 0.107 2 
D8 # Hubs 1.00 ±0.00a 1.00 ±0.00a 1.33 ±1.32a Chi 0.000 1.000 2 
D8 # Radii 31.11 ±4.46a 30.29 ±5.09a 29.80 ±4.15a f 0.144 0.867 2 
D8 Free Zone Area 14.59 ±5.13a 13.50 ±5.39a 8.68 ±4.69a f 2.229 0.136 2 
D8 Eccentricity 0.37 ±0.21a 0.45 ±0.09a 0.36 ±0.21a Chi 0.451 0.798 2 
D8 Capture Spiral Area 316.91 ±128.77a 327.64 ±75.78a 172.12 ±40.26b f 4.437 0.027 2 
D16 % Perfect Radii 0.66 ±0.50a 0.70 ±0.48a 0.82 ±0.18a Chi 0.512 0.774 2 
D16 Average Cell Height 0.24 ±0.09a 0.28 ±0.10a 0.40 ±0.27a Chi 2.552 0.279 2 
D16 # Hubs 0.67 ±0.50b 0.71 ±0.49ab 1.33 ±0.71a Chi 5.840 0.054 2 
D16 # Radii 31.11 ±6.05a 29.60 ±9.71a 25.67 ±12.56a f 0.676 0.522 2 
D16 Free Zone Area 16.47 ±6.23a 14.15 ±5.81a 11.54 ±12.40a f 0.479 0.628 2 
D16 Eccentricity 0.46 ±0.08a 0.28 ±0.37a 0.35 ±0.53a Chi 1.061 0.588 2 
D16 Capture Spiral Area 359.96 ±42.99a 326.75 ±88.79ab 165.67 
±141.47b 
Chi 5.671 0.059 2 
Table SI-3.0 Statistical results for P. agrestis  
  
 
 
 
 
 
 
 
Test Variable Control 4-MMC p value Df
1a Max Amplitude 74.81 ±31.58a 54.25 ±24.26b W 1153 0.001 1
1a Velocity 146.18 ±98.05a 124.22 ±102.27a W 954 0.204 1
1b Max Amplitude 76.27 ±45.58a 62.14 ±39.19a W 1046 0.139 1
Mean & SD for Treatment
Test Statistic
Table SI-3.0
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Figure SI-1.0 13C NMR Spectrum of 4-TFMMC (2)  
  
 
Figure SI-1. 1 13C NMR Spectrum of R.4-TFMMC (3)  
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Figure SI-1. 2 13C NMR Spectrum of 4-TFMC (4)  
  
  
Figure SI-1. 3 13C NMR Spectrum of R.4-TFMC (5)  
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Figure SI-2.0 19F NMR Spectrum of 4-TFMMC (2)  
  
  
Figure SI-2.1 19F NMR Spectrum of R.4-TFMMC (3)  
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Figure SI-2.2 19F NMR Spectrum of 4-TFMC (4)  
  
  
Figure SI-2.3 19F NMR Spectrum of R.4-TFMC (5)  
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Figure SI-3.0 Gradient enhanced HMBC spectrum of 4-TFMMC (2)  
  
  
Figure SI-3.1 Gradient enhanced HMBC spectrum of R.4-TFMMC (3)  
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Figure  SI-3.2  Gradient  enhanced  HMBC  spectrum  of  4-TFMC  (4)  
  
  
Figure  SI-3.3  Gradient  enhanced  HMBC  spectrum  of  R.4-TFMC  (5) 
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Figure SI-4.0 Gradient enhanced HMBC with X-decoupling spectrum of 4-TFMMC (2)  
  
  
Figure SI-4.1 Gradient enhanced HMBC with X-decoupling spectrum of R.4-TFMMC  
(3)   
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Figure SI-4.2 Gradient enhanced HMBC with X-decoupling spectrum of 4-TFMC (4)  
  
  
Figure SI-4.3 Gradient enhanced HMBC with X-decoupling spectrum of R.4TFMC (5)  
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SI-5.0 FTIR Spectrum of 4-TFMMC (2)  
 
  
Figure SI-5.1 FTIR Spectrum of R.4-TFMMC (3)  
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Figure SI-5.2 FTIR Spectrum of 4-TFMC (4)  
 
  
Figure SI-5.3 FTIR Spectrum of R.4-TFMC (5)  
  
